Improving the effectiveness of anti-aging modalities by using the constrained disorder principle-based management algorithms

Abstract

Aging is a complex biological process with multifactorial nature underlined by genetic, environmental, and social factors. In the present paper, we review several mechanisms of aging and the pre-clinically and clinically studied anti-aging therapies. Variability characterizes biological processes from the genome to cellular organelles, biochemical processes, and whole organs’ function. Aging is associated with alterations in the degrees of variability and complexity of systems. The constrained disorder principle defines living organisms based on their inherent disorder within arbitrary boundaries and defines aging as having a lower variability or moving outside the boundaries of variability. We focus on associations between variability and hallmarks of aging and discuss the roles of disorder and variability of systems in the pathogenesis of aging. The paper presents the concept of implementing the constrained disease principle-based second-generation artificial intelligence systems for improving anti-aging modalities. The platform uses constrained noise to enhance systems’ efficiency and slow the aging process. Described is the potential use of second-generation artificial intelligence systems in patients with chronic disease and its implications for the aged population.

Introduction

Aging is one of the most complex biological processes due to its multifactorial nature, involving genetic, environmental, and social factors. Human life expectancy continually rises, from 67 years in 2000 to 73.4 years in 2019 (World Health Organization, 2022). Sixty years and older subjects account for 25% of the total population in several European countries. By 2050, a quarter of the world population, not including Africa, may reach that proportion (Xu et al., 2019). As life expectancy continues to rise, there is a need to maintain quality of life and a healthy life expectancy (Kennedy et al., 2014).

Keeping the aged generation active and independent reduces the aging dependency rate (Kingston et al., 2017; Motamed-Jahromi and Kaveh, 2020). It is also associated with reducing costs for the senior population suffering from more chronic morbidity and improved quality of life (Foster and Walker, 2015; Maresova et al., 2019).

Variability characterizes the proper function of biological systems (Ilan, 2019a). The constrained disorder principle defines living organisms and non-living systems based on their disorder within arbitrary boundaries (Longo et al., 2012; Ilan, 2020a).

In the present paper, we review several mechanisms of aging and some anti-aging therapies. We reviewed studies that describe the associations between variability and aging by searching for variability and the hallmarks of aging. Studies were selected from the last 10 years using variability and hallmarks of aging search words.

The paper presents the concept of implementing the constrained disorder principle-based second-generation artificial intelligence (AI) systems for improving anti-aging interventions. The paper describes studies that present the concept of using variability for improving systems functions in biology and discuss the applicability of the concept to aging.

The constrained disorder principle defines living organisms and non-living systems

The combination of order and disorder underlies the normal function of biological systems at the level of the genome, cellular organism, and whole organs (Ilan, 2019a; Ilan, 2019b; Ilan, 2020b; Ilan, 2021b). The constrained disorder principle defines living organisms as disorders bounded by arbitrary dynamic boundaries (Ilan, 2021b). The constrained disorder principle provides systems with the flexibility and adaptability to function under continuously changing internal and external random environments. Per the principle, aging can be viewed as a malfunction of biological systems. Systems malfunctions are associated with a decrease or increase in the degree of disorder, limiting their ability to cope with changes and decreasing their function (Ilan, 2021b).

Variability characterizes biological systems

The notion of complexity in biological systems evolves from non-linear dynamics and determines the output of physiologic processes that generate variable fluctuations resembling “chaos.” (Ilan, 2019a; Ilan, 2019b; Ilan, 2020b) Non-linear dynamics enable evaluating biological systems’ complexity using the mathematical concepts of chaos theory and fractals (Nicolini et al., 2012). Variability is a hallmark of systems’ complexity that characterizes biological systems (Ilan, 2019a; Ilan, 2019b; Ilan, 2020b). Rearrangements at the genome level comprise genomic alterations that determine the genome stability and plasticity of the genome (Pellestor et al., 2021). Dynamic variability describes the function of microtubules in all cells (Mitchison and Kirschner, 1984; Ilan, 2019c; Ilan, 2019d; Ilan-Ber and Ilan, 2019; Forkosh et al., 2020). Variability is inherent to the immune system’s response to stimuli and characterizes the process of whole organs manifested in heart rate, breathing, blood pressure, and gait variability (Goldberger, 1996; Costa and Goldberger, 2019; El-Haj et al., 2019; Bencivenga et al., 2022).

The hallmarks of aging are associated with variability: Inter and intra-subject variabilities impact the process of aging

The hallmarks of aging, including genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient-sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication, are of relevance for developing new interventions for aging (López-Otín et al., 2013). New hallmarks of aging comprise autophagy, microbiome disturbance, altered mechanical properties, splicing dysregulation, and inflammation (Lemoine, 2021; Schmauck-Medina et al., 2022).

Aging is a multifactorial biological process, and the altered complexity and variability contribute and are reflected by the additional aging machineries (Xu et al., 2019). Each mechanism alone does not explain the complexity of aging, and this is a multifactorial process. A progressive function impairment during aging increases vulnerability to environmental challenges and is a growing risk of disease and death (Kirkwood, 2005).

Telomere attrition indicates accelerated biological aging (Maxwell et al., 2011). Telomere attrition contributes to increased morbidity and mortality in subjects with chronic and aging-related diseases (Xu et al., 2019; Wang et al., 2018a; D'Mello et al., 2015; Dai et al., 2014). Mitochondrial dysfunction and reactive oxygen species are associated with telomere attrition (Liu et al., 2002). Reintroducing telomerase in mice models reverses the tissue degeneration and the accelerated-aging phenotype (Jaskelioff et al., 2011; Sahin et al., 2011).

Shortening telomerase is associated with disturbances in the immune system and inflammation, increased pro-inflammatory cytokine tumor necrosis factor α that characterizes older adults, and increased risk for Alzheimer’s disease, diabetes, and cardiovascular diseases (von Zglinicki, 2002; Fulop et al., 2017; Herrmann et al., 2018; Spittau, 2017). Telomerase lengthening occurs with low alcohol consumption, cigarette smoking, a healthy diet, and physical activity (Latifovic et al., 2016; Sellami et al., 2021).

In contrast, other studies showed increased complexity and variability during aging (Kyriazis, 2003). Recent studies showed that HRV indices do not reflect the cardiac neuroautonomic function due to the assumption that the amplitude of variations in sinus normal-to-normal intervals are associated with the degree of vagal tone modulation. The vagal activity decreases with aging, reflected by a reduction in short-term HRV values. However, the data showed a counterintuitive increase in short-term/high-frequency variability in high-risk individuals (Huikuri and Stein, 2012; Drawz et al., 2013; Raman et al., 2017). The high HRV in diminished vagal tone modulation settings was termed the “HRV paradox.” (Costa et al., 2017a; Hayano et al., 2019; Hayano and Yuda, 2019; Yuda et al., 2020a; Yuda et al., 2020b; Yuda et al., 2021) Heart rate fragmentation (HRF) is a property of HR dynamics reflecting the altered sinoatrial pacemaker-neuroautonomic function that resolves this paradox (Costa et al., 2017a; Costa et al., 2017b). In older adults, HRF manifests itself by an increase in the density of heart rate acceleration sign changes and is not explainable by modulation of the cardiac vagal tone (Costa et al., 2017a; Costa et al., 2017b; Costa et al., 2018; Costa and Goldberger, 2019; Costa et al., 2021; Omoto et al., 2021). HRF supports an underlying variability that characterizes cardiac function, increases in older adults, and correlates with cardiovascular events (Costa and Goldberger, 2019). Interventions that slight or reverse aging decrease HRF (Gorelick et al., 2011; Collins et al., 2012; Alonso et al., 2013; Costa et al., 2018; Costa and Goldberger, 2019; Costa et al., 2021).

Blood Pressure Variability (BPV) is associated with organ damage and exerts independent predictive value on cardiovascular events, neurocognitive impairment, metabolic disorders, sarcopenia, and frailty (Bencivenga et al., 2022). BPV is associated with several age-related mechanisms, including genomic instability, epigenetic modification, and mitochondrial oxidative damage (Woo et al., 2018; Ma et al., 2020; Bencivenga et al., 2022; Jia et al., 2022). Altered BPV is associated with arterial stiffness and autonomic dysfunction in older adults. Subclinical inflammation associated with aging is also related to BP dysregulation via altered endothelial function (Seals et al., 2011; Donato et al., 2018).

The growth hormone induces the insulin/insulin-like growth factor (IGF) pathway. It controls tumorigenesis, diabetes, and cardiovascular diseases associated with aging (Tullet et al., 2008; Lee and Kim, 2018). Growth hormone deficiency or resistance extends lifespan in mice, with a decreased IGF-1 level (Bartke, 2008). Inhibition of IGF-1/insulin signaling extends the lifespan of C. elegans (Bartke, 2008; Tullet et al., 2008).

Overall the data supports the importance of altered variability in biological systems in the aging process. It supports the notion that intra and inter-subject variabilities are relevant to the aging hallmarks and processes. It goes along with the constrained disorder principle, which means that aging is associated with out-of-borders disorders. In some cases, it can involve a decrease and, in others, an increase in variability.

Heterogeneity of aging

Aging involves different degrees of inter-individual heterogeneity and is not a homogeneous process. Inter-individual heterogeneity refers to the differences between subjects in the aged group and between old and younger individuals. In addition to the inter-individual variability, alterations in the degree of intra-subject variability underlie the aging process. Age-associated increase in inter and intra-individual heterogeneity is substantiated by health-related quality of life, independence in activities of daily living (ADLs), psychomotor and cognitive tasks, and gene expression in the human brain. (Shammi et al., 1998; Lowsky et al., 2014; Kedlian et al., 2019) Older adults are more heterogeneous than younger adults (Nguyen et al., 2021). A large-scale study examined the heterogeneity of 34 health characteristics in eight domains amongst age groups ranging from 45 to 86 years. Systolic blood pressure, bone mineral density, some physical performance measures, chronic condition count, and most of the laboratory values tested were among the variables that demonstrated a statistically significant increase in heterogeneity with age. Several characteristics demonstrated a decrease in heterogeneity, and some showed no association of heterogeneity with age (Nguyen et al., 2021).

Several environmental factors contribute to the heterogeneity of aging, including socioeconomic status, social engagement, exercise, pharmacological treatment, and diet (Lowsky et al., 2014; Tejedor and Fraga, 2017). These factors impact the accumulation of degenerative processes in the aging individual. A higher degree of heterogeneity was demonstrated in the older population in their response to medications (McLachlan et al., 2009). Age-related mechanisms of altered drug metabolism, distribution, and interactions were proposed to underlie this phenomenon (McLachlan et al., 2009).

Chronological age is a poor predictor of adverse health outcomes and does not represent the complexity and variability of aging (Vaillant and Mukamal, 2001; Lowsky et al., 2014; Khan et al., 2017; Mitnitski et al., 2017). When examining genetically identical living models (single cells, tissues, or organisms), heterogeneity in aging is prominent, even under controlled environmental conditions, suggesting that additional factors contribute to this phenomenon (Kedlian et al., 2019; Neupert and Zhu, 2020; Nguyen et al., 2021; Shadel et al., 2021). Aging is associated with a decline in function, yet many older adults remain functional with no disability even at a very advanced age (Vaillant and Mukamal, 2001; Lowsky et al., 2014).

Potential biomarkers for aging include physical function measures, a variety of standard laboratory tests reflecting cardiovascular, hormonal, or inflammatory status, and markers based on DNA/epigenetic alterations, protein modifications, and miRNAs (Bürkle et al., 2015; Wagner et al., 2016; Tejedor and Fraga, 2017). Frailty explains the heterogeneity in life expectancy in individuals of the same age. It is a phenotype predictive of adverse health outcomes in older people. (Zaslavsky et al., 2013; Ribeiro et al., 2020) The “frailty index” evolved from the understanding that heterogeneity in health is measured using a deficit accumulation approach. It quantifies biological age by counting a range of clinically apparent health deficits, dividing the result by the total number of items measured (Mitnitski et al., 2017). The “complexity theory” may explain the dynamic nature of frailty (Lipsitz and Goldberger, 1992; Zaslavsky et al., 2013). It suggests that a decline in the “complex network of communicating physiological signals” lowers the ability to cope with stressors and leads to greater clinical susceptibility or frailty.

Overall the data support the relevance of inter and intra-subject variability in the pathogenesis of aging.

The constrained disorder principle defines aging as moving outside the boundaries of variability

Aging is associated with altered variability in biological systems (Gusso et al., 2019). Per the constrained disorder principle, a marked increase or decrease in the degree of variability, or getting outside of the constrained borders, underlie the aging process.

A loss of physiological complexity from molecular to cellular and tissue to organismic levels was proposed to be associated with aging, leading to an impaired ability to adapt to stress and numerous internal and external stimuli (Kyriazis, 2003). Age-related loss of complex variability is reflected by multiple processes, including cardiovascular control, electroencephalographic potentials, and pulsatile hormone release (Kyriazis, 1991; Lipsitz and Goldberger, 1992). The non-linear prediction method combined with Gaussian-scaled surrogate data can determine the chaotic behavior of the interspike interval of ventral tegmental area dopaminergic neurons in rats as a function of age. The complexity of action potentials and the chaotic content of ventral tegmental area dopamine neurons are reduced with aging (Di Mascio et al., 1999).

The correlation between aging and the variability or entropy of different cardiovascular parameters, including systolic and diastolic blood pressure, heart rate, and oxygenated hemoglobin, was examined in several studies. Some of these have demonstrated reduced variability with aging or frailty, while others have shown the reverse association (Fukusaki et al., 2000; Viola et al., 2011; Nemati et al., 2013; Toosizadeh et al., 2022; Ogliari et al., 2016; Knight et al., 2020; Lee et al., 2022).

Anti-aging interventions: Pre-clinical studies are inconsistent

Numerous anti-aging interventions were effective in pre-clinical studies, while only a minority showed some effect in controlled clinical studies (Blagosklonny, 2017; Klimova et al., 2018; Piskovatska et al., 2019).

Calorie restriction (CR) without malnutrition is one of the most studied anti-aging interventions (Bao et al., 2020). Caloric restriction (CR) refers to the total amount of calories that limit daily intake when providing sufficient nutrients such as essential amino acids and vitamins to ensure the organism does not suffer from malnutrition (Bao et al., 2020). Fasting and CR activate autophagy and upregulate autophagy markers improving organ function (Bi et al., 2018). CR extends the life span in several models, including mice, yeasts, flies, and worms. (Gomez-Delgado et al., 2018) The mechanism involves activating AMP protein kinase (AMPK) and sirtuins, inhibiting IGF-1 signaling, and inhibiting the mammalian target of rapamycin (mTOR). (Son et al., 2019) CR in monkeys prevented hyperinsulinemia and improved longevity by mitigating age-related diseases (Bodkin et al., 2003). CR alleviated morbidity and mortality among monkeys with reduced incidence of diabetes, cancer, cardiovascular disease, and brain atrophy and improved age-related and all-cause survival. (Colman et al., 2009; Colman et al., 2014) CR prevents the aggregation of degenerative mitochondria in aging cells by activating autophagy (Bao et al., 2020).

“CR mimetics” (CRM) are compounds that activate signaling pathways and enhance longevity, similar to CR. The glycolytic inhibitor 2-deoxy-D-glucose (2DG) is a CRM that extends lifespan in rats and C. elegans and exerts benefits in cerebral ischemic damage and neurodegenerative disorders (Saraswat and Rizvi, 2017).

Rapamycin, a macrolide isolated from Streptomyces bacteria, is CRM used as an immunosuppressive agent. It acts as an mTOR inhibitor that modulates autophagy, delays aging and increases lifespan in fruit flies and mice (Harrison et al., 2009; Bjedov et al., 2010).

Polyphenols, curcumin, and Resveratrol are CRM molecules. Curcumin is a food additive known for its anti-aging properties. It inhibits lipid peroxidation, neutralizes several oxidative molecules, including ROS, increases HO-1 in the brain and vascular cells, and may inhibit NFkB activation (Calabrese et al., 2012). Curcumin increases lifespan in D. melanogaster (Brouet and Ohshima, 1995; Suckow and Suckow, 2006; Lee et al., 2010a; Lee et al., 2010b; Lee et al., 2010c; Shen et al., 2013).

Resveratrol activates Sirt1 and is an anti-inflammatory, anti-tumoral, and anti-oxidant agent (Gomez-Delgado et al., 2018). It extends the lifespan in Drosophila when fed a high-fat diet related to NAD + dependent histone deacetylase, Sir2 (Bass et al., 2007; Wang et al., 2013). Low resveratrol doses improved vascular function and aerobic capacity and decreased senescence markers in rats but did not extend lifespan (da Luz et al., 2012). It benefits DM2, cardiovascular morbidity, Alzheimer’s disease, and cancer (Son et al., 2019).

The IGF-1 signaling pathway has importance on longevity, and a reduced GH/IGF-1 axis protects from cancer, diabetes, and age-related diseases. GH receptor antagonist (pegvisomant) reduces IGF-1 circulating levels, increases insulin sensitivity, and impacts longevity (Trainer et al., 2000; Junnila et al., 2013).

Metformin is a biguanide that reduces gastrointestinal glucose absorption, inhibits gluconeogenesis, is an antioxidant, and acts as CRM (Glossmann and Lutz, 2019; Mohammed et al., 2021). It increases the activity of antioxidant enzymes in erythrocytes and malondialdehyde reduction, decreasing oxidative stress in T2D subjects (Bang et al., 2014; Abad-Jimenez et al., 2020; Ahmed Mobasher et al., 2020). It reduces inflammation, activates autophagy, diminishes oxidative damage, and acts as an anti-aging agent (Gomez-Delgado et al., 2018; Son et al., 2019). Metformin reduces the amounts of advanced glycation end-products (AGEs) that contribute to cellular senescence and target-organ damage in T2D, neurodegeneration, and inflammation (Haddad et al., 2016; Diamanti-Kandarakis et al., 2017).

Aspirin acts as a CRM. Besides its known anti-inflammatory activity, it activates AMPK and reduces mTORC1, enhancing autophagy (Williams et al., 2009; Saraswat and Rizvi, 2017). It is beneficial in extending the median lifespan in mice (Strong et al., 2008; Madeo et al., 2019). Non-steroidal anti-inflammatory drugs extended the lifespan in various model organisms increasing the locomotor activity and stress resistance in Drosophila (Poole et al., 2004; Danilov et al., 2015). The cyclooxygenase-2 (COX-2) inhibitor celecoxib extends C. elegans lifespan (Ching et al., 2011). Celecoxib is a histone deacetylase (HDAC) inhibitors (Pasyukova and Vaiserman, 2017).

Plant-based diets modulate energy-sensing pathways and involve AMPK, target mTOR, nuclear factor erythroid 2-related factor 2 (Nrf2), sirtuin-1, fox head box O(FOXO), and peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1α) (Martel et al., 2021). Plant-rich diets that include phytochemicals activate anti-oxidant gene expression. Sulforaphane, found in edible plants (i.e., broccoli), induces the classical Nrf2-target gene and enhances neuroprotection. Sulforaphane administration attenuates water channel aquaporin-4 (AQP4) loss in the traumatic brain injury model (Zhao et al., 2005).

Protein restriction affects mTORC1 regulation and circulating branched amino acids. (Solon-Biet et al., 2014) Restriction of several amino acids impacts several metabolic processes, i.e., methionine reduced liver steatosis in mice. The ketogenic diet (KD) increases protein acetylation, regulates mTOR signaling, reduces midlife mortality, and improves memory in aging mice (Newman and Verdin, 2017; Roberts et al., 2018). KD promotes longevity in mice with enhanced motor function (Balietti et al., 2010; Kovacs et al., 2021). A high-fat diet and a KD reverse lifespan shortening and attenuate the premature aging phenotype in a mouse model (Xu et al., 2019).

Vitamin E or α-tocopherol extends the lifespan of flies (Dias-Santagata et al., 2007). Vitamin C, an anti-oxidant, did not affect nematode lifespan (Harrington and Harley, 1988). Anti-oxidant dietary supplementation augments the Drosophila melanogaster, longevity (Brack et al., 1997). Riboflavin supplementation and melatonin prevent oxidative damage (Zou et al., 2017). Nordihydroguaiaretic acid (NDGA) extends the lifespan of flies (Miquel et al., 1982). Anti-oxidant intakes, such as polyphenols, can increase the telomere length (Maleki et al., 2020).

Metabolic intermediates include oxaloacetate supplementation, malate, TCA metabolite, fumarate and succinate, and α-ketoglutarate, a tricarboxylic acid cycle intermediate that increases the lifespan of C. elegans (Williams et al., 2009).

Selective elimination of senescent cells using senolytic agents is explored as an anti-aging strategy (van Deursen, 2014; Saraswat and Rizvi, 2017; Melo Pereira et al., 2019). Natural compounds (i.e., quercetin, piperlongumine, and fisetin), BCL2 inhibitors, FOXO4-interacting peptides, HSP90 inhibitors, histone deacetylase inhibitors, and Tyrosine Kinase inhibitors show senolytic activity. Dasatinib, a tyrosine kinase inhibitor, combined with quercetin, increased lifespan and improved daily function in mice. (Ogrodnik et al., 2017; Gomez-Delgado et al., 2018; Xu et al., 2018)

Lithium extends C. elegans lifespan via an epigenetic mechanism by altering the expression of genes encoding nucleosome-associated functions (McColl et al., 2008; Wan et al., 2013). Lithium in low doses but not at high dosages extended fly lifespan by inhibiting glycogen synthase kinase-3 (GSK-3) and activating the nuclear erythroid 2-related factor (NRF-2) transcription factor (Castillo-Quan et al., 2016).

Minocycline, a metabolite in the formation of kynurenine from tryptophan, exerts anti-inflammatory, antioxidant, and neuroprotective properties increasing Drosophila survival (Oxenkrug et al., 2012).

Natural product molecules can delay the aging process by influencing metabolic pathways (Muzammil et al., 2021). Blueberry polyphenols, quercetin, and ginkgo biloba extracts extend C. elegans lifespan (Wilson et al., 2006; Pietsch et al., 2009). Cocoa increased lifespan in D. melanogaster and demonstrated anti-oxidant properties (Bahadorani and Hilliker, 2008). Rosemary (Rosmarinus officinalis L.) is known for its anti-oxidant activity, causes longevity in Drosophila, and is associated with increased superoxide dismutase and catalase activities (Wang et al., 2017). Ludwigia octovalvis (LOE) is a rich source of antioxidants, including polyphenol compounds, phytosterols, and squalene, and it extends the lifespan of fruit flies (Lin et al., 2014).

Epigenetic alterations affect senescence and cellular mitotic competence. (Herrera et al., 2008; Melo Pereira et al., 2019) Enhanced histone deacetylases (HDAC) activity is involved divergent processes, including inflammation, differentiation, apoptosis, and autophagy. Inhibitors of HDACs extend lifespan (Chen et al., 2015; Pasyukova and Vaiserman, 2017). A lifespan-extending effect in Drosophila was shown for 4-phenylbutyrate treatment by histone (de)acetylation (Kang et al., 2002). Spermidine induces autophagy and prolongs the lifespan of aging animals (LaRocca et al., 2013).

Anti-aging interventions: Clinical studies lack validated data

In humans, there is a lack of validated information for most anti-aging medications (Liu, 2022). While multiple studies show the potential positive effects of different compounds in various living organisms, most lack clinical evidence in humans. Many of the interventions balance between expected positive effects and unavoidable adverse side effects.

Metformin reduced levels of IL-6, TNF-α pro-inflammatory cytokines in the serum, and MCP-1 in the urine of T2D patients and reduced the inflammatory responses in the systemic circulation (Cameron et al., 2016). Several studies showed that metformin is effective against cognitive decline, while others claimed that exposure to metformin contributes to neurodegeneration, Parkinson and Alzheimer’s disease (Ng et al., 2014; Hervas et al., 2017). DM2 patients treated with metformin as monotherapy had better survival than non-diabetic matched controls (Bannister et al., 2014).

Rapamycin, combined with medications capable of controlling the adverse effects of rapalogs, such as statins and metformin, might be a promising strategy to control age-associated diseases (Martinet et al., 2014; Blagosklonny, 2017; Leontieva and Blagosklonny, 2017). Rapamycin analogs, everolimus, and temsirolimus may delay age-related processes, including neurodegenerative disease and cardiac hypertrophy, and maintain stem cells’ regenerative capacity (Saraswat and Rizvi, 2017; Kraig et al., 2018).

Statins have anti-inflammatory, immunomodulatory, anti-oxidant, and antiproliferative effects, stabilize atherosclerotic plaques, prevent aggregation of platelets, and carry the potential for treatment and prevention of multiple age-related diseases (Kavalipati et al., 2015; Oesterle et al., 2017). Meta-analysis of 92 placebo-controlled and active-comparator trials demonstrated that statins are effective for primary and secondary cardiovascular prevention, reducing major coronary events and all-cause mortality by reducing oxidative stress and inflammatory markers (Naci et al., 2013; Shimomura et al., 2016; Gilbert et al., 2017). Statins induce apoptosis, cause cytostatic and antiproliferative effects, augment anticarcinogenic properties of standard chemotherapies, and attenuate cancer cell migration and invasion (Papanagnou et al., 2017).

Anti-lipolytic drugs mimic calorie restriction, triggering autophagy to alleviate the aging process. Anti-lipolytic drugs such as Acipimox reduce blood lipids, inhibit the release of free fatty acids from whole-body fat tissue, reduce the synthesis of cholesterol and triglyceride, reduce the total cholesterol level triacyl and low-density lipoprotein in plasma and exert anti-oxidant effects (Bao et al., 2020).

Regulation of inflammation can serve as an anti-aging intervention. However, the lack of large trials makes it difficult to draw final conclusions (Neves and Sousa-Victor, 2020). A meta-analysis of nine trials where aspirin was used for primary cardiovascular prevention in 100,076 patients showed that long-term aspirin reduced myocardial infarction, ischemic stroke, and all-cause mortality (Raju et al., 2016). A recent meta-analysis involving data from 36,196 patients did not confirm the protective effect of aspirin on cognitive decline in older age. Pooled data from RCTs and observational studies showed that low-dose aspirin was not associated with better cognition or improved cognitive impairment (Veronese et al., 2017).

Dietary supplementation with large doses of anti-oxidants had no preventive or therapeutic effect (Biswas, 2016; Ros and Carrascosa, 2020). A Mediterranean diet rich in monounsaturated fatty acids, such as olive oil, increases the telomerase length (Gomez-Delgado et al., 2018). Increasing the levels of beta-carotene and alpha-tocopherol in healthy adults’ diets protects telomere length (Yabuta et al., 2016). The Okinawan diet includes more fresh vegetables and fruits, and fewer proteins from fish and soy were proposed to improve health (Nilholm et al., 2018).

In humans, CR protects from arthritis, cardiovascular diseases, age-related diabetes, colon lesions, delayed osteoporosis, sarcopenia, brain atrophy, and cognitive decline, and decreases cancer incidence and progression (Balasubramanian et al., 2017). A low-calorie diet was associated with lower mortality, cardiovascular events, and cancer (Kagawa, 1978). Trials of CR in humans, the CALERIE trials (Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy) and CRON (Caloric Restriction with Optimal Nutrition) showed that improved glucose tolerance, decreased LDL levels, decreased C-Reactive Protein levels, better blood pressure control, and reduced 10-year risk of cardiovascular events (wustlWUSoMCGWEPRSBVDTFLS-MKSKBKSHJOj et al., 2006; Larson-Meyer et al., 2010; Most et al., 2018). The CRON trial showed reduced risk factors associated with DM2 atherosclerosis and cardiovascular disease (Fontana et al., 2004; Fontana et al., 2010). CR decreases intramyocellular lipid content, blood pressure, total cholesterol, LDL cholesterol, C-reactive protein, TNFα, and 10-year risk of cardiovascular disease (Das et al., 2007; Rochon et al., 2011; Stewart et al., 2013).

Time-restricted feeding (TRF) limits the daily food intake to 8 h or less. Intermittent fasting (IF) designates eating patterns in which individuals go extended periods (e.g., 16–48 h) with little/no energy intake. The fasting and mimicking diets (FMD) include diets that mimic fasting, affecting the expression pattern of different tissues based on circadian signaling rhythm. TRF induces gene expressions, including mTOR and AMPK, that enhance the circadian clock’s oscillations and positively affect metabolic control. (Hatori et al., 2012) TRF without CR reduced metabolic alterations such as hyperinsulinemia, inflammation, hepatic steatosis, and insulin resistance (Hatori et al., 2012; Tinsley and La Bounty, 2015; Mitchell et al., 2019). FMD twice a month from middle age extends longevity, reduces visceral fat and cancer incidence, and rejuvenates the immune system while hampering bone mineral density loss (Brandhorst et al., 2015).

Numerous natural products may exert anti-aging properties, among them Arbutin, Ramulus mori extract, Licorice extract, Glabridin, Liquiritin, Kojic acid, Methyl gentisate, Aloesin, Azelaic acid, Vitamin C, Thioctic acid, Soya bean extracts, Niacinamide, α and β-hydroxy acids, Lactic acid, Chamomile extract, Ellagic acid, tea contains polyphenols, carotenoids, tocopherols, ascorbic acid, minerals, and certain phytochemicals (Zaid and Al Ramahi, 2019). A cross-sectional study found that using natural products by older adult Chinese men is positively associated with telomere length (Cabrera et al., 2006; Huang et al., 2016; Kamal et al., 2021).

Non-pharmacological approaches to delay age-related decline, including diet and physical activity, can provide some life-extending and disease-preventing benefits (McPhee et al., 2016; Di Daniele et al., 2017; Piskovatska et al., 2019). Hormesis postulates that mild to moderate biological stress can induce an adaptive response that activates several cellular pathways ameliorating lifespan and changing homeostasis. Oppositely, the stress of higher intensity can be deleterious (Gomez-Delgado et al., 2018).

The limited effectiveness of currently tested interventions on the potential to improve longevity and the complexity of developing new mechanisms and therapeutic targets implies a need to provide methods for enhancing the effectiveness of currently available regimens.

Improving the response to chronic medications using the constrained disorder principle

Variability characterizes biological systems and provides a mechanism for surviving under numerous random internal and external stimuli (Ilan, 2019a; Ilan, 2019b; Ilan, 2019c; Ilan, 2019d; El-Haj et al., 2019; Ilan, 2019f; Ilan-Ber and Ilan, 2019; Ilan, 2020b; Forkosh et al., 2020). The constrained disorder principle defines aging as the malfunctioning of biological systems due to loss of variability or moving out of the boundaries of variability. The principle provides an anti-aging platform based on increasing the disorder in the natural system in cases where it is reduced or tightening disorder boundaries when the disorder is increased (Ilan, 2021b).

Anti-aging therapies mandate prolonged chronic treatment. One of the reasons for the lack of effectiveness of chronic pharmacological and non-pharmacological interventions is the human body’s compensatory responses, which lead to the development of tolerance to this intrusions (Ilan, 2020c). The compensatory mechanisms that lead to a lack of a sustainable response evolve from mechanisms that differ between subjects and interventions (Ilan, 2020c). The compensatory responses lead to partial or complete loss of response in up to half of the users of numerous agents, including anti-inflammatory agents, anti-cancer drugs; anti-depressants, anti-epileptics analgesics, medical cannabis-based products, metabolic agents, and others (Ilan, 2019e; Ilan, 2019f; Kenig and Ilan, 2019; Khoury and Ilan, 2019; Ilan, 2020c; Gelman et al., 2020; Ilan and Spigelman, 2020; Kessler et al., 2020; Potruch et al., 2020; Ilan, 2021a; Ishay et al., 2021a; Azmanov et al., 2021; Ishay et al., 2021b; Hurvitz et al., 2021; Isahy and Ilan, 2021; Kenig et al., 2021; Khoury and Ilan, 2021; Kolben et al., 2021; Azmanov et al., 2022; Gelman et al., 2022). Compensatory mechanisms also underlie the plateaus effects in training and other non-pharmacological interventions, hindering the ability to achieve a long-term effect (Gelman et al., 2022).

The “loss of complexity” mechanism accompanying the aging process suggests prescribing medications in an irregular, non-linear manner (i.e., unpredictable dosage change and drug administration timing) (Kyriazis, 2003). It has been proposed that other external stimuli, such as nutrition and social meetings, should also be planned to regain complexity (Kyriazis, 2003).

The constrained disorder principle provides a method for overcoming these compensatory effects using variability-based therapeutic regimens and anti-aging interventions (Ilan, 2021b). The principle provides a platform that can improve the effectiveness of current medications and non-pharmacological interventions. Regimens that showed promising results in pre-clinical models but failed to show similar results in humans and those with only limited results can be improved by implementing the constrained-disorder principle-based approach (Ilan, 2020d).

The role of variability in anti-aging intervention

Several anti-aging regimens incorporate the concept of variability. While the mechanisms underlying metformin responses in humans remain largely unknown, they can be explained by genetic variability. Organic cation transporter 1 (OCT1) plays a role in the hepatic uptake of metformin and affects AMPK activation. In mice hepatocytes, deletion of OCT1 reduced the effects of metformin on AMPK phosphorylation and gluconeogenesis in mice. Subjects with OCT1 polymorphism have reduced responses to metformin (Soukas et al., 2019). In OCT1-deficient mice, the glucose-lowering effects of metformin were abolished. Seven polymorphisms of OCT1 that exhibited reduced metformin uptake were identified. Clinical trials have shown that glucose tolerance was significantly lower in individuals with reduced function polymorphisms. The data support that genetic variation in OCT1 may contribute to variation in metformin respones (Shu et al., 2007).

Metformin’s anti-aging effect varies between species (Soukas et al., 2019); studies have shown metformin to extend the longevity of certain organisms (worm, caged mice) but not others (fruit fly), a fact that may be attributed to their variable nutrient availability and their intensity of exercise. The glycemic effect of metformin varies between individuals, whereas researchers attempt to decipher the genetic and environmental differences distinguishing between responders to non-responders (Florez, 2017). The genetic variability in metformin metabolism is an example of reduced function polymorphisms and the differences between subjects.

The association between aging and gut microbiota constitutes an eminent illustration of variability’s application. Reduced gut microbiota diversity and increased colonization by opportunistic species characterize the process of aging. The gut microbiota of centenarians is more diverse than that of younger adults. (Cӑtoi et al., 2020) Age-related altered gut microbiota profile includes loss of genes for short-chain fatty acids (SCFA) production with decreased saccharolytic and increased proteolytic bacteria, leading to pathobionts’ dominance and contributing to inflamma-aging. While the described age-related alterations in the microbiome are between subjects and between older and younger individuals, intra-subject changes which evolve from responses to internal and external triggers are of importance (Ilan, 2019e).

A systematic review and meta-analysis determined the effect of short-term probiotic supplementation in older adults on the immune system. (Miller et al., 2019) A short-term, 3–12 weeks, probiotic supplementation improved the cellular immune function in healthy older adults. A longer duration of 6 months of probiotic supplementation altered the gut microbiota structure by inducing the proliferation of beneficial microorganisms and positively affecting individuals’ health. These data suggest that variability in the duration of administration impacts the outcome.

The data support that several anti-aging therapeutics are linked to the variability in their underlying mechanisms and molecular pathways. The heterogeneous responses to therapies can be attributed to genetic, metabolic, and environmental variability among subjects. While most studies focus on the heterogeneity between younger and aged populations and the inter-individual variability among the aged population, there is also an essential role for the intra-subject variability. Both inter and intra-subject variabilities are mandatory for proper flexibility and adaptability to continuous internal and external perturbations.

The constrained disorder principle provides a method for improving the effectiveness of anti-aging therapies using second-generation artificial intelligence systems

The constrained disorder principle provides a platform for second-generation artificial intelligence (AI) systems that regulate therapeutic regimens and non-pharmacological interventions (Ilan, 2023). Second-generation AI systems are based on the concept that biological systems are dynamic, and their behavior continuously changes among and between subjects (Ilan, 2020d). These systems implement the n = 1 notion and closed-loops algorithms that constantly adapt to changes. They use but are independent of big data sets, which are the basis for most first-generation AI systems that lack accuracy and relevance to a single subject. Most big data sets prevent an ability of dynamicity, which is behind every biological function (Ilan, 2020c; Ilan, 2020d; Ilan, 2021b; Ilan, 2022).

Table 1 demonstrates examples of implementing the constrained disorder principle-based methods for improving anti-aging programs. Second-generation AI systems that implement variability within borders can be used with each example to improve the response to therapies and achieve a sustainable reaction.

The described second-generation AI systems provide a method for implementing intra-subject variability-based interventions generated based on capturing and quantifying inter and intra-individual variability signatures (Ilan, 2021b).

The second-generation AI algorithm is developed in three stages. The first is an open-loop system that sets up regimens comprising variability in the dosing and administration times of the intervention. This step is not dependent on input and does not account for the outputs. For aging, incorporating variability may be sufficient for improving clinically meaningful outcomes (Ilan, 2020d; Ilan, 2021b). The concept implies that for maximum benefit, anti-aging pharmacological and non-pharmacological interventions should be administered at irregular, pulsed, or multiple intervals and at changing dosage strengths. Maintaining various external and internal physiological stimuli, such as variable physical and mental exercise regimes, can slow the aging procesess (Kyriazis, 2003).

In the second stage, an outcome-based closed-loop system is implemented. The system adapts itself to clinically meaningful endpoints irrespective of the input. It provides a method for tailoring the degree of variability of the intervention in a personalized way. It can overcome the task in cases where the degree of disorder is challenging to measured (Ilan, 2020d; Ilan, 2021b).

In the third stage, the platform implements signatures of variability into the algorithm. This step is essential for improving aging processes, as relevant signatures may be lower or higher than required. An example is the use of heart-based variability regimens. HRV and HRF comprise measures of the intrinsic variability of cardiac function and correlate with cognitive functions. Irrespective of the method used for calculating the HRV, it is clear that the variability is altered with aging. Similarly, looking into inflamm-aging, where cytokine secretion variability is quantified and implemented as a dynamic variable into the algorithm’s input layer (Ilan, 2020d; Ilan, 2021b).

The digital pill comprises any drug that a second-generation AI-based app regulates its administration (Naci et al., 2013). The first level involves randomization of the dosing and times of administration of a drug within the approved ranges that the physician sets up. For the second level, clinical endpoints are pre-defined, and closed-loop tailors the variability to the treatment regimens in a personalized way. It enables tailoring the variability regiments to the patient’s response in a dynamic way that keeps changing. In the third level, the system quantifies the variability measures and implements them into the algorithm for generating therapeutic regimens to improve the response rate to chronic anti-aging therapies (Ilan, 2020c; Ilan, 2020d; Ilan, 2021b; Ilan, 2022). Quantifying measures of variability and implementing them into the algorithm in a patient-tailored dynamic way provide a method to incorporate personalized variabilities into treatment algorithms aiming at overcoming the loss of response (Ilan, 2021b).

Figure 1 presents a schematic description of the potential associations between the hallmarks of aging and the concepts of complexity and variability. It provides examples of links between the variabilities of aging hallmarks and age-related diseases. The figure illustrates the method for implementing variability into anti-aging interventions to improve their effectiveness using constrained-disorder principle-based second-generation AI systems. Per this principle, maintaining variability within a controlled range may alleviate the aging process and improve anti-aging interventions. The figure highlights the potential of quantifying variability signatures of the hallmarks and implementing them into the algorithm. It provides a comprehensive scheme associating the variability of the hallmarks with age-related diseases and personalized treatment algorithms, paving the way for improved targeted anti-aging interventions. The system enables enhancing internal variability when the degree of variability is too low or regulating it when it is too high.

FIGURE 1

Implementing variability into therapeutic regimens of anti-aging drugs, such as metformin, statins, anti-oxidants, and all types of medications and natural products, which showed some efficacy in pre-clinical and clinical studies, is expected to improve the response to these drugs. In parallel, using the digital pill with anti-depressants, anti-diabetics, cardiac drugs, chronic analgesics, anti-cancer drugs, and other medications which are commonly used in the aged population is expected to overcome the compensatory mechanisms and increase the response rate and the clinical benefits from these medications, improving quality of life and increasing lifespan (Ilan, 2019e; Ilan, 2019f; Kenig and Ilan, 2019; Khoury and Ilan, 2019; Gelman et al., 2020; Ilan and Spigelman, 2020; Kessler et al., 2020; Potruch et al., 2020; Ilan, 2021a; Ishay et al., 2021a; Azmanov et al., 2021; Ishay et al., 2021b; Hurvitz et al., 2021; Isahy and Ilan, 2021; Kenig et al., 2021; Khoury and Ilan, 2021; Kolben et al., 2021; Azmanov et al., 2022; Gelman et al., 2022).

The second-generation AI system can enhance the effectiveness of exercise, physiotherapy, and mind-targeted regimens, by implementing controlled variability into the interventions (Gelman et al., 2022). Using the constrained-disorder principle-based, AI is expected to improve the response to these interventions and ensure a long-term sustainable response (Gelman et al., 2022). Weight regain is a significant obstacle to the use of anti-aging dietary regimens. The compensatory mechanisms that evolve from altered hormone secretion and chronobiology mechanisms imply a lack of sustainable effects of the dietary-based intervention (Khoury and Ilan, 2021). Using a second-generation AI system provides a method for ensuring the long-term effectiveness of dietary procedures by introducing variability into the diets, thus overcoming the compensatory metabolic responses which hinder long-term responses (Khoury and Ilan, 2021).

Summary

Aging is a multifactorial process, and it is unlikely that a single mechanism, and thus a single agent, can resolve it. Altered variability and complexity are found in aging and may underlie some of the above-described tools. Studies showed decreased or increased variability in older adults, per the constrained disorder principle, which implies getting the variability out of the dynamic boundaries. While multiple attempts to improve longevity with numerous compounds are continuously being tested pre-clinically and clinically, their overall effectiveness is limited and lacks validation. The described second-generation AI-based platform provides a system for improving the effectiveness of the currently used drugs and interventions. Ongoing studies are expected to shed light on their potential for overcoming the lack of response to interventions and increasing longevity.

References

• 1

  Abad-JimenezZ.Lopez-DomenechS.Diaz-RuaR.IannantuoniF.Gómez-AbrilS. A.Periañez-GómezD.et al (2020). Systemic Oxidative Stress and Visceral Adipose Tissue Mediators of NLRP3 Inflammasome and Autophagy Are Reduced in Obese Type 2 Diabetic Patients Treated with Metformin, 9.Antioxidants (Basel)

  • Google Scholar

• 2

  AbdellatifM.SedejS.KroemerG. (2021). NAD(+) metabolism in cardiac health, aging, and disease. Circulation144, 1795–1817. 10.1161/CIRCULATIONAHA.121.056589

  • CrossRef
  • Google Scholar

• 3

  Ahmed MobasherM.Galal El-TantawiH.Samy El-SaidK. (2020). Metformin ameliorates oxidative stress induced by diabetes mellitus and hepatocellular carcinoma in rats. Rep. Biochem. Mol. Biol.9, 115–128. 10.29252/rbmb.9.1.115

  • CrossRef
  • Google Scholar

• 4

  AlaM.AlaM. (2021). Metformin for cardiovascular protection, inflammatory bowel disease, osteoporosis, periodontitis, polycystic ovarian syndrome, neurodegeneration, cancer, inflammation and senescence: What is next?ACS Pharmacol. Transl. Sci.4, 1747–1770. 10.1021/acsptsci.1c00167

  • CrossRef
  • Google Scholar

• 5

  AlcendorR. R.GaoS.ZhaiP.ZablockiD.HolleE.YuX.et al (2007). Sirt1 regulates aging and resistance to oxidative stress in the heart. Circ. Res.100, 1512–1521. 10.1161/01.RES.0000267723.65696.4a

  • CrossRef
  • Google Scholar

• 6

  AlonsoA.KrijtheB. P.AspelundT.StepasK. A.PencinaM. J.MoserC. B.et al (2013). Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: The CHARGE-AF consortium. J. Am. Heart Assoc.2, e000102. 10.1161/JAHA.112.000102

  • CrossRef
  • Google Scholar

• 7

  AlùF.OrticoniA.JudicaE.CotelliM.RossiniP. M.MiragliaF.et al (2021). Entropy modulation of electroencephalographic signals in physiological aging. Mech. Ageing Dev.196, 111472. 10.1016/j.mad.2021.111472

  • CrossRef
  • Google Scholar

• 8

  AngarolaB. L.AnczukówO. (2021). Splicing alterations in healthy aging and disease, 12. Wiley Interdiscip Rev RNA, e1643.

  • Google Scholar

• 9

  AyadM. T.TaylorB. D.MenonR. (2018). Regulation of p38 mitogen-activated kinase-mediated fetal membrane senescence by statins. Am. J. Reprod. Immunol.80, e12999. 10.1111/aji.12999

  • CrossRef
  • Google Scholar

• 10

  AzmanovH.BayatraA.IlanY. (2022). Digital analgesic comprising a second-generation digital health system: Increasing effectiveness by optimizing the dosing and minimizing side effects. J. Pain Res.15, 1051–1060. 10.2147/JPR.S356319

  • CrossRef
  • Google Scholar

• 11

  AzmanovH.RossE. L.IlanY. (2021). Establishment of an individualized chronotherapy, autonomic nervous system, and variability-based dynamic platform for overcoming the loss of response to analgesics. Pain Physician24, 243–252. 10.36076/ppj.2021/24/243

  • CrossRef
  • Google Scholar

• 12

  BahadoraniS.HillikerA. J. (2008). Cocoa confers life span extension in Drosophila melanogaster. Nutr. Res.28, 377–382. 10.1016/j.nutres.2008.03.018

  • CrossRef
  • Google Scholar

• 13

  BalasubramanianP.HowellP. R.AndersonR. M. (2017). Aging and caloric restriction research: A biological perspective with translational potential. EBioMedicine21, 37–44. 10.1016/j.ebiom.2017.06.015

  • CrossRef
  • Google Scholar

• 14

  BaliettiM.CasoliT.Di StefanoG.GiorgettiB.AicardiG.FattorettiP. (2010). Ketogenic diets: An historical antiepileptic therapy with promising potentialities for the aging brain. Ageing Res. Rev.9, 273–279. 10.1016/j.arr.2010.02.003

  • CrossRef
  • Google Scholar

• 15

  Ballesteros-ÁlvarezJ.AndersenJ. K. m. T. O. R. C2 (2021). mTORC2: The other mTOR in autophagy regulation. Aging Cell.20, e13431. 10.1111/acel.13431

  • CrossRef
  • Google Scholar

• 16

  BangS.ChenY.AhimaR. S.KimS. F. (2014). Convergence of IPMK and LKB1-AMPK signaling pathways on metformin action. Mol. Endocrinol.28, 1186–1193. 10.1210/me.2014-1134

  • CrossRef
  • Google Scholar

• 17

  BannisterC. A.HoldenS. E.Jenkins-JonesS.MorganC. L.HalcoxJ. P.SchernthanerG.et al (2014). Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls. Diabetes Obes. Metab.16, 1165–1173. 10.1111/dom.12354

  • CrossRef
  • Google Scholar

• 18

  BaoJ.LiuB.WuC. (2020). Progress of anti-aging drugs targeting autophagy. Adv. Exp. Med. Biol.1207, 681–688. 10.1007/978-981-15-4272-5_50

  • CrossRef
  • Google Scholar

• 19

  BartkeA. (2008). Impact of reduced insulin-like growth factor-1/insulin signaling on aging in mammals: Novel findings. Aging Cell.7, 285–290. 10.1111/j.1474-9726.2008.00387.x

  • CrossRef
  • Google Scholar

• 20

  BassT. M.WeinkoveD.HouthoofdK.GemsD.PartridgeL. (2007). Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans. Mech. Ageing Dev.128, 546–552. 10.1016/j.mad.2007.07.007

  • CrossRef
  • Google Scholar

• 21

  BencivengaL.De Souto BarretoP.RollandY.HanonO.VidalJ. S.CestacP.et al (2022). Blood pressure variability: A potential marker of aging. Ageing Res. Rev.80, 101677. 10.1016/j.arr.2022.101677

  • CrossRef
  • Google Scholar

• 22

  Bernardes de JesusB.BlascoM. A. (2013). Telomerase at the intersection of cancer and aging. Trends Genet.29, 513–520. 10.1016/j.tig.2013.06.007

  • CrossRef
  • Google Scholar

• 23

  BhadraM.HowellP.DuttaS.HeintzC.MairW. B. (2020). Alternative splicing in aging and longevity. Hum. Genet.139, 357–369. 10.1007/s00439-019-02094-6

  • CrossRef
  • Google Scholar

• 24

  BiS.WangH.KuangW. (2018). Stem cell rejuvenation and the role of autophagy in age retardation by caloric restriction: An update. Mech. Ageing Dev.175, 46–54. 10.1016/j.mad.2018.07.005

  • CrossRef
  • Google Scholar

• 25

  BiswasS. K. (2016). Does the interdependence between oxidative stress and inflammation explain the antioxidant paradox?Oxid. Med. Cell. Longev.2016, 5698931. 10.1155/2016/5698931

  • CrossRef
  • Google Scholar

• 26

  BjedovI.ToivonenJ. M.KerrF.SlackC.JacobsonJ.FoleyA.et al (2010). Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster. Cell. Metab.11, 35–46. 10.1016/j.cmet.2009.11.010

  • CrossRef
  • Google Scholar

• 27

  BlackburnE. H. (2005). Telomeres and telomerase: Their mechanisms of action and the effects of altering their functions. FEBS Lett.579, 859–862. 10.1016/j.febslet.2004.11.036

  • CrossRef
  • Google Scholar

• 28

  BlagosklonnyM. V. (2017). From rapalogs to anti-aging formula. Oncotarget8, 35492–35507. 10.18632/oncotarget.18033

  • CrossRef
  • Google Scholar

• 29

  BodkinN. L.AlexanderT. M.OrtmeyerH. K.JohnsonE.HansenB. C. (2003). Mortality and morbidity in laboratory-maintained Rhesus monkeys and effects of long-term dietary restriction. J. Gerontol. A Biol. Sci. Med. Sci.58, 212–219. 10.1093/gerona/58.3.b212

  • CrossRef
  • Google Scholar

• 30

  BoyetteL. B.TuanR. S. (2014). Adult stem cells and diseases of aging. J. Clin. Med.3, 88–134. 10.3390/jcm3010088

  • CrossRef
  • Google Scholar

• 31

  BrackC.Bechter-ThuringE.LabuhnM. (1997). N-acetylcysteine slows down ageing and increases the life span of Drosophila melanogaster. Cell. Mol. Life Sci.53, 960–966. 10.1007/pl00013199

  • CrossRef
  • Google Scholar

• 32

  BrandhorstS.ChoiI. Y.WeiM.ChengC. W.SedrakyanS.NavarreteG.et al (2015). A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan. Cell. Metab.22, 86–99. 10.1016/j.cmet.2015.05.012

  • CrossRef
  • Google Scholar

• 33

  BrouetI.OhshimaH. (1995). Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem. Biophys. Res. Commun.206, 533–540. 10.1006/bbrc.1995.1076

  • CrossRef
  • Google Scholar

• 34

  BulutO.KilicG.Dominguez-AndresJ. (2021). Immune memory in aging: A wide perspective covering microbiota, brain, metabolism, and epigenetics. Clin. Rev. Allergy Immunol.

  • Google Scholar

• 35

  BürkleA.Moreno-VillanuevaM.BernhardJ.BlascoM.ZondagG.HoeijmakersJ. H. J.et al (2015). MARK-AGE biomarkers of ageing. Mech. Ageing Dev.151, 2–12. 10.1016/j.mad.2015.03.006

  • CrossRef
  • Google Scholar

• 36

  CabreraC.ArtachoR.GimenezR. (2006). Beneficial effects of green tea-a review. J. Am. Coll. Nutr.25, 79–99. 10.1080/07315724.2006.10719518

  • CrossRef
  • Google Scholar

• 37

  CalabreseV.CorneliusC.Dinkova-KostovaA. T.IavicoliI.Di PaolaR.KoverechA.et al (2012). Cellular stress responses, hormetic phytochemicals and vitagenes in aging and longevity. Biochim. Biophys. Acta1822, 753–783. 10.1016/j.bbadis.2011.11.002

  • CrossRef
  • Google Scholar

• 38

  CameronA. R.MorrisonV. L.LevinD.MohanM.ForteathC.BeallC.et al (2016). Anti-inflammatory effects of metformin irrespective of diabetes status. Circ. Res.119, 652–665. 10.1161/CIRCRESAHA.116.308445

  • CrossRef
  • Google Scholar

• 39

  CarrardG.BulteauA-L.PetropoulosI.FriguetB. (2002). Impairment of proteasome structure and function in aging. Int. J. Biochem. Cell. Biol.34, 1461–1474. 10.1016/s1357-2725(02)00085-7

  • CrossRef
  • Google Scholar

• 40

  Castelo-BrancoC.SoveralI. (2014). The immune system and aging: A review. Gynecol. Endocrinol.30, 16–22. 10.3109/09513590.2013.852531

  • CrossRef
  • Google Scholar

• 41

  Castillo-QuanJ. I.LiL.KinghornK. J.IvanovD. K.TainL. S.SlackC.et al (2016). Lithium promotes longevity through GSK3/NRF2-dependent hormesis. Cell. Rep.15, 638–650. 10.1016/j.celrep.2016.03.041

  • CrossRef
  • Google Scholar

• 42

  CӑtoiA. F.CorinaA.KatsikiN.VodnarD. C.AndreicuțA. D.StoianA. P.et al (2020). Gut microbiota and aging-A focus on centenarians. Biochim. Biophys. Acta. Mol. Basis Dis.1866, 165765. 10.1016/j.bbadis.2020.165765

  • CrossRef
  • Google Scholar

• 43

  ChenL.TanK. M. L.GongM.ChongM. F. F.TanK. H.ChongY. S.et al (2022). Variability in newborn telomere length is explained by inheritance and intrauterine environment. BMC Med.20, 20. 10.1186/s12916-021-02217-9

  • CrossRef
  • Google Scholar

• 44

  ChenY.DuJ.ZhaoY. T.ZhangL.LvG.ZhuangS.et al (2015). Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice. Cardiovasc. Diabetol.14, 99. 10.1186/s12933-015-0262-8

  • CrossRef
  • Google Scholar

• 45

  CheungP.VallaniaF.WarsinskeH. C.DonatoM.SchaffertS.ChangS. E.et al (2018). Single-cell chromatin modification profiling reveals increased epigenetic variations with aging. Cell.173, 1385–1397. e14. 10.1016/j.cell.2018.03.079

  • CrossRef
  • Google Scholar

• 46

  ChingT. T.ChiangW. C.ChenC. S.HsuA. L. (2011). Celecoxib extends C. elegans lifespan via inhibition of insulin-like signaling but not cyclooxygenase-2 activity. Aging Cell.10, 506–519. 10.1111/j.1474-9726.2011.00688.x

  • CrossRef
  • Google Scholar

• 47

  CollinoS.MontoliuI.MartinF. P.SchererM.MariD.SalvioliS.et al (2013). Metabolic signatures of extreme longevity in northern Italian centenarians reveal a complex remodeling of lipids, amino acids, and gut microbiota metabolism. PLoS One8, e56564. 10.1371/journal.pone.0056564

  • CrossRef
  • Google Scholar

• 48

  CollinsO.DillonS.FinucaneC.LawlorB.KennyR. A. (2012). Parasympathetic autonomic dysfunction is common in mild cognitive impairment. Neurobiol. Aging33, 2324–2333. 10.1016/j.neurobiolaging.2011.11.017

  • CrossRef
  • Google Scholar

• 49

  ColmanR. J.AndersonR. M.JohnsonS. C.KastmanE. K.KosmatkaK. J.BeasleyT. M.et al (2009). Caloric restriction delays disease onset and mortality in rhesus monkeys. Science325, 201–204. 10.1126/science.1173635

  • CrossRef
  • Google Scholar

• 50

  ColmanR. J.BeasleyT. M.KemnitzJ. W.JohnsonS. C.WeindruchR.AndersonR. M. (2014). Caloric restriction reduces age-related and all-cause mortality in rhesus monkeys. Nat. Commun.5, 3557–3565. 10.1038/ncomms4557

  • CrossRef
  • Google Scholar

• 51

  ConciatoriF.CiuffredaL.BazzichettoC.FalconeI.PilottoS.BriaE.et al (2018). mTOR cross-talk in cancer and potential for combination therapy. Cancers10, 23. 10.3390/cancers10010023

  • CrossRef
  • Google Scholar

• 52

  ConteM.MartucciM.ChiarielloA.FranceschiC.SalvioliS. (2020). Mitochondria, immunosenescence and inflammaging: A role for mitokines?Semin. Immunopathol.42, 607–617. 10.1007/s00281-020-00813-0

  • CrossRef
  • Google Scholar

• 53

  CoppeJ. P.DesprezP. Y.KrtolicaA.CampisiJ. (2010). The senescence-associated secretory phenotype: The dark side of tumor suppression. Annu. Rev. Pathol.5, 99–118. 10.1146/annurev-pathol-121808-102144

  • CrossRef
  • Google Scholar

• 54

  CostaM. D.DavisR. B.GoldbergerA. L. (2017). Heart rate fragmentation: A new approach to the analysis of cardiac interbeat interval dynamics. Front. Physiol.8, 255. 10.3389/fphys.2017.00255

  • CrossRef
  • Google Scholar

• 55

  CostaM. D.DavisR. B.GoldbergerA. L. (2017). Heart rate fragmentation: A symbolic dynamical approach. Front. Physiol.8, 827. 10.3389/fphys.2017.00827

  • CrossRef
  • Google Scholar

• 56

  CostaM. D.GoldbergerA. L. (2019). Heart rate fragmentation: Using cardiac pacemaker dynamics to probe the pace of biological aging. Am. J. Physiol. Heart Circ. Physiol.316, H1341-H1344–H1344. 10.1152/ajpheart.00110.2019

  • CrossRef
  • Google Scholar

• 57

  CostaM. D.RedlineS.DavisR. B.HeckbertS. R.SolimanE. Z.GoldbergerA. L. (2018). Heart rate fragmentation as a novel biomarker of adverse cardiovascular events: The multi-ethnic study of atherosclerosis. Front. Physiol.9, 1117. 10.3389/fphys.2018.01117

  • CrossRef
  • Google Scholar

• 58

  CostaM. D.RedlineS.HughesT. M.HeckbertS. R.GoldbergerA. L. (2021). Prediction of cognitive decline using heart rate fragmentation analysis: The multi-ethnic study of atherosclerosis. Front. Aging Neurosci.13, 708130. 10.3389/fnagi.2021.708130

  • CrossRef
  • Google Scholar

• 59

  CrewsD. E.IceG. H. (2012). Aging, senescence, and human variation. Human biology: An evolutionary and biocultural perspective, 637–692.

  • Google Scholar

• 60

  CrimminsE. M. (2020). Social hallmarks of aging: Suggestions for geroscience research. Ageing Res. Rev.63, 101136. 10.1016/j.arr.2020.101136

  • CrossRef
  • Google Scholar

• 61

  CristofariG.LingnerJ. (2006). Telomere length homeostasis requires that telomerase levels are limiting. Embo J.25, 565–574. 10.1038/sj.emboj.7600952

  • CrossRef
  • Google Scholar

• 62

  D'MelloM. J.RossS. A.BrielM.AnandS. S.GersteinH.PareG. (2015). Association between shortened leukocyte telomere length and cardiometabolic outcomes: Systematic review and meta-analysis. Circ. Cardiovasc. Genet.8, 82–90. 10.1161/CIRCGENETICS.113.000485

  • CrossRef
  • Google Scholar

• 63

  da LuzP. L.TanakaL.BrumP. C.DouradoP. M. M.FavaratoD.KriegerJ. E.et al (2012). Red wine and equivalent oral pharmacological doses of resveratrol delay vascular aging but do not extend life span in rats. Atherosclerosis224, 136–142. 10.1016/j.atherosclerosis.2012.06.007

  • CrossRef
  • Google Scholar

• 64

  DaiD. F.ChiaoY. A.MarcinekD. J.SzetoH. H.RabinovitchP. S. (2014). Mitochondrial oxidative stress in aging and healthspan. Longev. Heal.3, 6. 10.1186/2046-2395-3-6

  • CrossRef
  • Google Scholar

• 65

  DanilovA.ShaposhnikovM.ShevchenkoO.ZemskayaN.ZhavoronkovA.MoskalevA. (2015). Influence of non-steroidal anti-inflammatory drugs on Drosophila melanogaster longevity. Oncotarget6, 19428–19444. 10.18632/oncotarget.5118

  • CrossRef
  • Google Scholar

• 66

  DasS. K.GilhoolyC. H.GoldenJ. K.PittasA. G.FussP. J.CheathamR. A.et al (2007). Long-term effects of 2 energy-restricted diets differing in glycemic load on dietary adherence, body composition, and metabolism in CALERIE: A 1-y randomized controlled trial. Am. J. Clin. Nutr.85, 1023–1030. 10.1093/ajcn/85.4.1023

  • CrossRef
  • Google Scholar

• 67

  de LuciaC.MurphyT.StevesC. J.DobsonR. J. B.ProitsiP.ThuretS. (2020). Lifestyle mediates the role of nutrient-sensing pathways in cognitive aging: Cellular and epidemiological evidence. Commun. Biol.3, 157. 10.1038/s42003-020-0844-1

  • CrossRef
  • Google Scholar

• 68

  DemanelisK.JasmineF.ChenL. S.ChernoffM.TongL.DelgadoD.et al (2020). Determinants of telomere length across human tissues. Science369, eaaz6876. 10.1126/science.aaz6876

  • CrossRef
  • Google Scholar

• 69

  DheinS.HammerathS. B. (2001). Aspects of the intercellular communication in aged hearts: Effects of the gap junction uncoupler palmitoleic acid. Naunyn. Schmiedeb. Arch. Pharmacol.364, 397–408. 10.1007/s002100100462

  • CrossRef
  • Google Scholar

• 70

  Di DanieleN.NoceA.VidiriM. F.MoriconiE.MarroneG.Annicchiarico-PetruzzelliM.et al (2017). Impact of Mediterranean diet on metabolic syndrome, cancer and longevity. Oncotarget8, 8947–8979. 10.18632/oncotarget.13553

  • CrossRef
  • Google Scholar

• 71

  Di MascioM.Di GiovanniG.Di MatteoV.EspositoE. (1999). Reduced chaos of interspike interval of midbrain dopaminergic neurons in aged rats. Neuroscience89, 1003–1008. 10.1016/s0306-4522(98)00702-7

  • CrossRef
  • Google Scholar

• 72

  Diamanti-KandarakisE.PapalouO.KandarakiE. A.KassiG. (2017). Mechanisms in endocrinology: Nutrition as A mediator of oxidative stress in metabolic and reproductive disorders in women. Eur. J. Endocrinol.176, R79-R99–R99. 10.1530/EJE-16-0616

  • CrossRef
  • Google Scholar

• 73

  Dias-SantagataD.FulgaT. A.DuttaroyA.FeanyM. B. (2007). Oxidative stress mediates tau-induced neurodegeneration in Drosophila. J. Clin. Investig.117, 236–245. 10.1172/JCI28769

  • CrossRef
  • Google Scholar

• 74

  DonatoA. J.MachinD. R.LesniewskiL. A. (2018). Mechanisms of dysfunction in the aging vasculature and role in age-related disease. Circ. Res.123, 825–848. 10.1161/CIRCRESAHA.118.312563

  • CrossRef
  • Google Scholar

• 75

  DrawzP. E.BabineauD. C.BrecklinC.HeJ.KallemR. R.SolimanE. Z.et al (2013). Heart rate variability is a predictor of mortality in chronic kidney disease: A report from the CRIC study. Am. J. Nephrol.38, 517–528. 10.1159/000357200

  • CrossRef
  • Google Scholar

• 76

  DuY.GaoY.ZengB.FanX.YangD.YangM. (2021). Effects of anti-aging interventions on intestinal microbiota. Gut Microbes13, 1994835. 10.1080/19490976.2021.1994835

  • CrossRef
  • Google Scholar

• 77

  DufourE.LarssonN. G. (2004). Understanding aging: Revealing order out of chaos. Biochim. Biophys. Acta1658, 122–132. 10.1016/j.bbabio.2004.04.020

  • CrossRef
  • Google Scholar

• 78

  El-HajM.KanovitchD.IlanY. (2019). Personalized inherent randomness of the immune system is manifested by an individualized response to immune triggers and immunomodulatory therapies: A novel platform for designing personalized immunotherapies. Immunol. Res.67, 337–347. 10.1007/s12026-019-09101-y

  • CrossRef
  • Google Scholar

• 79

  Fafián-LaboraJ. A.O’LoghlenA. (2020). Classical and nonclassical intercellular communication in senescence and ageing. Trends Cell. Biol.30, 628–639. 10.1016/j.tcb.2020.05.003

  • CrossRef
  • Google Scholar

• 80

  FangY.TangS.LiX. (2019). Sirtuins in metabolic and epigenetic regulation of stem cells. Trends Endocrinol. Metab.30, 177–188. 10.1016/j.tem.2018.12.002

  • CrossRef
  • Google Scholar

• 81

  FlorezJ. C. (2017). The pharmacogenetics of metformin. Diabetologia60, 1648–1655. 10.1007/s00125-017-4335-y

  • CrossRef
  • Google Scholar

• 82

  FontanaL.KleinS.HolloszyJ. O. (2010). Effects of long-term calorie restriction and endurance exercise on glucose tolerance, insulin action, and adipokine production. Age32, 97–108. 10.1007/s11357-009-9118-z

  • CrossRef
  • Google Scholar

• 83

  FontanaL.MeyerT. E.KleinS.HolloszyJ. O. (2004). Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc. Natl. Acad. Sci. U. S. A.101, 6659–6663. 10.1073/pnas.0308291101

  • CrossRef
  • Google Scholar

• 84

  FooteC. G.VleckD.VleckC. M. (2013). Extent and variability of interstitial telomeric sequences and their effects on estimates of telomere length. Mol. Ecol. Resour.13, 417–428. 10.1111/1755-0998.12079

  • CrossRef
  • Google Scholar

• 85

  ForkoshE.KenigA.IlanY. (2020). Introducing variability in targeting the microtubules: Review of current mechanisms and future directions in colchicine therapy. Pharmacol. Res. Perspect.8, e00616. 10.1002/prp2.616

  • CrossRef
  • Google Scholar

• 86

  FosterL.WalkerA. (2015). Active and successful aging: A European policy perspective. Gerontologist55, 83–90. 10.1093/geront/gnu028

  • CrossRef
  • Google Scholar

• 87

  FranceschiC.CapriM.MontiD.GiuntaS.OlivieriF.SeviniF.et al (2007). Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev.128, 92–105. 10.1016/j.mad.2006.11.016

  • CrossRef
  • Google Scholar

• 88

  FranceschiC.GaragnaniP.PariniP.GiulianiC.SantoroA. (2018). Inflammaging: A new immune-metabolic viewpoint for age-related diseases. Nat. Rev. Endocrinol.14, 576–590. 10.1038/s41574-018-0059-4

  • CrossRef
  • Google Scholar

• 89

  FranceschiC.GaragnaniP.VitaleG.CapriM.SalvioliS. (2017). Inflammaging and 'garb-aging. Trends Endocrinol. Metab.28, 199–212. 10.1016/j.tem.2016.09.005

  • CrossRef
  • Google Scholar

• 90

  FranceschiC.SalvioliS.GaragnaniP.de EguileorM.MontiD.CapriM. (2017). Immunobiography and the heterogeneity of immune responses in the elderly: A focus on inflammaging and trained immunity. Front. Immunol.8, 982. 10.3389/fimmu.2017.00982

  • CrossRef
  • Google Scholar

• 91

  FranceschiC.SantoroA.CapriM. (2020). The complex relationship between immunosenescence and inflammaging: Special issue on the new biomedical perspectives. Semin. Immunopathol.42, 517–520. 10.1007/s00281-020-00823-y

  • CrossRef
  • Google Scholar

• 92

  FranceschiC.ZaikinA.GordleevaS.IvanchenkoM.BonifaziF.StorciG.et al (2018). Inflammaging 2018: An update and a model. Semin. Immunol.40, 1–5. 10.1016/j.smim.2018.10.008

  • CrossRef
  • Google Scholar

• 93

  FranzinR.StasiA.RanieriE.NettiG. S.CantaluppiV.GesualdoL.et al (2021). Targeting premature renal aging: From molecular mechanisms of cellular senescence to senolytic trials. Front. Pharmacol.12, 630419. 10.3389/fphar.2021.630419

  • CrossRef
  • Google Scholar

• 94

  FukusakiC.KawakuboK.YamamotoY. (2000). Assessment of the primary effect of aging on heart rate variability in humans. Clin. Auton. Res.10, 123–130. 10.1007/BF02278016

  • CrossRef
  • Google Scholar

• 95

  FulopT.LarbiA.DupuisG.Le PageA.FrostE. H.CohenA. A.et al (2017). Immunosenescence and inflamm-aging as two sides of the same coin: Friends or foes?Front. Immunol.8, 1960. 10.3389/fimmu.2017.01960

  • CrossRef
  • Google Scholar

• 96

  GalowA. M.PelegS. (2022). How to slow down the ticking clock: Age-associated epigenetic alterations and related interventions to extend life span. Cells11, 468. 10.3390/cells11030468

  • CrossRef
  • Google Scholar

• 97

  GaoJ.XuK.LiuH.LiuG.BaiM.PengC.et al (2018). Impact of the gut microbiota on intestinal immunity mediated by tryptophan metabolism. Front. Cell. Infect. Microbiol.8, 13. 10.3389/fcimb.2018.00013

  • CrossRef
  • Google Scholar

• 98

  GelinoS.HansenM. (2012). Autophagy - an emerging anti-aging mechanism. J. Clin. Exp. Pathol.Suppl 4, 006. 10.4172/2161-0681.s4-006

  • CrossRef
  • Google Scholar

• 99

  GelmanR.BayatraA.KesslerA.SchwartzA.IlanY. (2020). Targeting SARS-CoV-2 receptors as a means for reducing infectivity and improving antiviral and immune response: An algorithm-based method for overcoming resistance to antiviral agents. Emerg. Microbes Infect.9, 1397–1406. 10.1080/22221751.2020.1776161

  • CrossRef
  • Google Scholar

• 100

  GelmanR.BergM.IlanY. (2022). A subject-tailored variability-based platform for overcoming the plateau effect in sports training: A narrative review. Int. J. Environ. Res. Public Health19, 1722. 10.3390/ijerph19031722

  • CrossRef
  • Google Scholar

• 101

  GilbertR.Al-JanabiA.Tomkins-NetzerO.LightmanS. (2017). Statins as anti-inflammatory agents: A potential therapeutic role in sight-threatening non-infectious uveitis. Porto Biomed. J.2, 33–39. 10.1016/j.pbj.2017.01.006

  • CrossRef
  • Google Scholar

• 102

  GlaucheI.ThieleckeL.RoederI. (2011). Cellular aging leads to functional heterogeneity of hematopoietic stem cells: A modeling perspective. Aging Cell.10, 457–465. 10.1111/j.1474-9726.2011.00692.x

  • CrossRef
  • Google Scholar

• 103

  GlossmannH. H.LutzO. M. D. (2019). Metformin and aging: A review. Gerontology65, 581–590. 10.1159/000502257

  • CrossRef
  • Google Scholar

• 104

  GoldbergerA. L. (1996). Non-linear dynamics for clinicians: Chaos theory, fractals, and complexity at the bedside. Lancet347, 1312–1314. 10.1016/s0140-6736(96)90948-4

  • CrossRef
  • Google Scholar

• 105

  Gomez-DelgadoF.Delgado-ListaJ.Lopez-MorenoJ.Rangel-ZunigaO. A.Alcala-DiazJ. F.Leon-AcunaA.et al (2018). Telomerase RNA component genetic variants interact with the mediterranean diet modifying the inflammatory status and its relationship with aging: CORDIOPREV study. J. Gerontol. A Biol. Sci. Med. Sci.73, 327–332. 10.1093/gerona/glw194

  • CrossRef
  • Google Scholar

• 106

  GonzaloS. (2010). Epigenetic alterations in aging. J. Appl. Physiol.109, 586–597. 10.1152/japplphysiol.00238.2010

  • CrossRef
  • Google Scholar

• 107

  GorelickP. B.ScuteriA.BlackS. E.DecarliC.GreenbergS. M.IadecolaC.et al (2011). Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the American heart association/American stroke association. Stroke42, 2672–2713. 10.1161/STR.0b013e3182299496

  • CrossRef
  • Google Scholar

• 108

  GrubeK.BürkleA.BurkleA. (1992). Poly(ADP-ribose) polymerase activity in mononuclear leukocytes of 13 mammalian species correlates with species-specific life span. Proc. Natl. Acad. Sci. U. S. A.89, 11759–11763. 10.1073/pnas.89.24.11759

  • CrossRef
  • Google Scholar

• 109

  GuervilleF.De Souto BarretoP.AderI.AndrieuS.CasteiLLaL.DrayC.et al (2020). Revisiting the hallmarks of aging to identify markers of biological age. J. Prev. Alzheimers Dis.7, 56–64. 10.14283/jpad.2019.50

  • CrossRef
  • Google Scholar

• 110

  GuigozY.DoreJ.SchiffrinE. J. (2008). The inflammatory status of old age can be nurtured from the intestinal environment. Curr. Opin. Clin. Nutr. Metab. Care11, 13–20. 10.1097/MCO.0b013e3282f2bfdf

  • CrossRef
  • Google Scholar

• 111

  GussoA.DantasW. G.UjevicS. (2019). Prediction of robust chaos in micro and nanoresonators under two-frequency excitation. Chaos29, 033112. 10.1063/1.5058750

  • CrossRef
  • Google Scholar

• 112

  HaasR. H. (2019). Mitochondrial Dysfunction in Aging and Diseases of Aging, 8.Biol. (Basel)

  • Google Scholar

• 113

  HaddadM.KnaniI.BouzidiH.BerricheO.HammamiM.KerkeniM. (2016). Plasma levels of pentosidine, carboxymethyl-lysine, soluble receptor for advanced glycation end products, and metabolic syndrome: The metformin effect. Dis. Markers2016, 6248264. 10.1155/2016/6248264

  • CrossRef
  • Google Scholar

• 114

  HarmanD. (1956). Aging: The theory based on free radical and radiation chemistry with application to cancer and atherosclerosis. Rad. Lab. Calender Univ. Calif.-Berkeley3, 3.

  • Google Scholar

• 115

  HarringtonL. A.HarleyC. B. (1988). Effect of vitamin E on lifespan and reproduction in Caenorhabditis elegans. Mech. Ageing Dev.43, 71–78. 10.1016/0047-6374(88)90098-x

  • CrossRef
  • Google Scholar

• 116

  HarrisonD. E.StrongR.SharpZ. D.NelsonJ. F.AstleC. M.FlurkeyK.et al (2009). Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. nature460, 392–395. 10.1038/nature08221

  • CrossRef
  • Google Scholar

• 117

  HatoriM.VollmersC.ZarrinparA.DiTacchioL.BushongE. A.GillS.et al (2012). Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. Cell. Metab.15, 848–860. 10.1016/j.cmet.2012.04.019

  • CrossRef
  • Google Scholar

• 118

  HayanoJ.KisoharaM.YoshidaY.SakanoH.YudaE. (2019). Association of heart rate variability with regional difference in senility death ratio: ALLSTAR big data analysis. SAGE Open Med.7, 2050312119852259. 10.1177/2050312119852259

  • CrossRef
  • Google Scholar

• 119

  HayanoJ.YudaE. (2019). Pitfalls of assessment of autonomic function by heart rate variability. J. Physiol. Anthropol.38, 3. 10.1186/s40101-019-0193-2

  • CrossRef
  • Google Scholar

• 120

  HaydenM. S.GhoshS. (2008). Shared principles in NF-kappaB signaling. Cell.132, 344–362. 10.1016/j.cell.2008.01.020

  • CrossRef
  • Google Scholar

• 121

  HerndonL. A.SchmeissnerP. J.DudaronekJ. M.BrownP. A.ListnerK. M.SakanoY.et al (2002). Stochastic and genetic factors influence tissue-specific decline in ageing C. elegans. Nature419, 808–814. 10.1038/nature01135

  • CrossRef
  • Google Scholar

• 122

  HerreraL. A.PradaD.AndoneguiM. A.Duenas-GonzalezA. (2008). The epigenetic origin of aneuploidy. Curr. Genomics9, 43–50. 10.2174/138920208783884883

  • CrossRef
  • Google Scholar

• 123

  HerrmannM.PuscedduI.MarzW.HerrmannW. (2018). Telomere biology and age-related diseases. Clin. Chem. Lab. Med.56, 1210–1222. 10.1515/cclm-2017-0870

  • CrossRef
  • Google Scholar

• 124

  HervasD.Fornes-FerrerV.Gomez-EscribanoA. P.SequedoM. D.PeiroC.MillanJ. M.et al (2017). Metformin intake associates with better cognitive function in patients with Huntington's disease. PLoS One12, e0179283. 10.1371/journal.pone.0179283

  • CrossRef
  • Google Scholar

• 125

  HuangC. C.TungY. T.HuangW. C.ChenY. M.HsuY. J.HsuM. C. (2016). Beneficial effects of cocoa, coffee, green tea, and garcinia complex supplement on diet induced obesity in rats. BMC Complement. Altern. Med.16, 100. 10.1186/s12906-016-1077-1

  • CrossRef
  • Google Scholar

• 126

  HuikuriH. V.SteinP. K. (2012). Clinical application of heart rate variability after acute myocardial infarction. Front. Physiol.3, 41. 10.3389/fphys.2012.00041

  • CrossRef
  • Google Scholar

• 127

  HurvitzN.AzmanovH.KeslerA.IlanY. (2021). Establishing a second-generation artificial intelligence-based system for improving diagnosis, treatment, and monitoring of patients with rare diseases. Eur. J. Hum. Genet.29, 1485–1490. 10.1038/s41431-021-00928-4

  • CrossRef
  • Google Scholar

• 128

  IlanY.SpigelmanZ. (2020). Establishing patient-tailored variability-based paradigms for anti-cancer therapy: Using the inherent trajectories which underlie cancer for overcoming drug resistance. Cancer Treat. Res. Commun.25, 100240. 10.1016/j.ctarc.2020.100240

  • CrossRef
  • Google Scholar

• 129

  IlanY. (2020). Advanced tailored randomness: A novel approach for improving the efficacy of biological systems. J. Comput. Biol.27, 20–29. 10.1089/cmb.2019.0231

  • CrossRef
  • Google Scholar

• 130

  IlanY. (2021). Digital medical cannabis as market differentiator: Second-generation artificial intelligence systems to improve response. Front. Med.8, 788777. 10.3389/fmed.2021.788777

  • CrossRef
  • Google Scholar

• 131

  IlanY. (2019). Generating randomness: Making the most out of disordering a false order into a real one. J. Transl. Med.17, 49. 10.1186/s12967-019-1798-2

  • CrossRef
  • Google Scholar

• 132

  IlanY. (2019). β-Glycosphingolipids as mediators of both inflammation and immune tolerance: A manifestation of randomness in biological systems. Front. Immunol.10, 1143. 10.3389/fimmu.2019.01143

  • CrossRef
  • Google Scholar

• 133

  IlanY. (2021). Improving global healthcare and reducing costs using second-generation artificial intelligence-based digital pills: A market disruptor. Int. J. Environ. Res. Public Health18, 811. 10.3390/ijerph18020811

  • CrossRef
  • Google Scholar

• 134

  IlanY. (2019). Microtubules: From understanding their dynamics to using them as potential therapeutic targets. J. Cell. Physiol.234, 7923–7937. 10.1002/jcp.27978

  • CrossRef
  • Google Scholar

• 135

  IlanY. (2022). Next-generation personalized medicine: Implementation of variability patterns for overcoming drug resistance in chronic diseases. J. Pers. Med.12, 1303. 10.3390/jpm12081303

  • CrossRef
  • Google Scholar

• 136

  IlanY. (2020). Order through disorder: The characteristic variability of systems. Front. Cell. Dev. Biol.8, 186. 10.3389/fcell.2020.00186

  • CrossRef
  • Google Scholar

• 137

  IlanY. (2020). Overcoming compensatory mechanisms toward chronic drug administration to ensure long-term, sustainable beneficial effects. Mol. Ther. Methods Clin. Dev.18, 335–344. 10.1016/j.omtm.2020.06.006

  • CrossRef
  • Google Scholar

• 138

  IlanY. (2019). Overcoming randomness does not rule out the importance of inherent randomness for functionality. J. Biosci.44, 132. 10.1007/s12038-019-9958-3

  • CrossRef
  • Google Scholar

• 139

  IlanY. (2019). Randomness in microtubule dynamics: An error that requires correction or an inherent plasticity required for normal cellular function?Cell. Biol. Int.43, 739–748. 10.1002/cbin.11157

  • CrossRef
  • Google Scholar

• 140

  IlanY. (2020). Second-generation digital health platforms: Placing the patient at the center and focusing on clinical outcomes. Front. Digit. Health2, 569178. 10.3389/fdgth.2020.569178

  • CrossRef
  • Google Scholar

• 141

  IlanY. (2022). The constrained disorder principle defines living organisms and provides a method for correcting disturbed biological systems Computational and Structural Biotechnology20, 6087–6096.

  • Google Scholar

• 142

  IlanY. (2019). Why targeting the microbiome is not so successful: Can randomness overcome the adaptation that occurs following gut manipulation?Clin. Exp. Gastroenterol.12, 209–217. 10.2147/CEG.S203823

  • CrossRef
  • Google Scholar

• 143

  Ilan-BerT.IlanY. (2019). The role of microtubules in the immune system and as potential targets for gut-based immunotherapy. Mol. Immunol.111, 73–82. 10.1016/j.molimm.2019.04.014

  • CrossRef
  • Google Scholar

• 144

  IsahyY.IlanY. (2021). Improving the long-term response to antidepressants by establishing an individualized platform based on variability and chronotherapy. Int. J. Clin. Pharmacol. Ther.59, 768–774. 10.5414/CP204000

  • CrossRef
  • Google Scholar

• 145

  IshayY.KolbenY.KesslerA.IlanY. (2021). Role of circadian rhythm and autonomic nervous system in liver function: A hypothetical basis for improving the management of hepatic encephalopathy. Am. J. Physiol. Gastrointest. Liver Physiol.321, G400–G412. 10.1152/ajpgi.00186.2021

  • CrossRef
  • Google Scholar

• 146

  IshayY.PotruchA.SchwartzA.BergM.JamilK.AgusS.et al (2021). A digital health platform for assisting the diagnosis and monitoring of COVID-19 progression: An adjuvant approach for augmenting the antiviral response and mitigating the immune-mediated target organ damage. Biomed. Pharmacother.143, 112228. 10.1016/j.biopha.2021.112228

  • CrossRef
  • Google Scholar

• 147

  IwabuM.Okada-IwabuM.YamauchiT.KadowakiT. (2015). Adiponectin/adiponectin receptor in disease and aging. NPJ Aging Mech. Dis.1, 15013. 10.1038/npjamd.2015.13

  • CrossRef
  • Google Scholar

• 148

  JaskelioffM.MullerF. L.PaikJ. H.ThomasE.JiangS.AdamsA. C.et al (2011). Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature469, 102–106. 10.1038/nature09603

  • CrossRef
  • Google Scholar

• 149

  JiaP.ZhanN.BatB. K. K.FengQ.TsoiK. K. F. (2022). The genetic architecture of blood pressure variability: A genome-wide association study of 9370 participants from UK biobank. J. Clin. Hypertens.24, 1370–1380. 10.1111/jch.14552

  • CrossRef
  • Google Scholar

• 150

  JunnilaR. K.ListE. O.BerrymanD. E.MurreyJ. W.KopchickJ. J. (2013). The GH/IGF-1 axis in ageing and longevity. Nat. Rev. Endocrinol.9, 366–376. 10.1038/nrendo.2013.67

  • CrossRef
  • Google Scholar

• 151

  KagawaY. (1978). Impact of westernization on the nutrition of Japanese: Changes in physique, cancer, longevity and centenarians. Prev. Med.7, 205–217. 10.1016/0091-7435(78)90246-3

  • CrossRef
  • Google Scholar

• 152

  KamalD. A. M.SalamtN.ZaidS. S. M.MokhtarM. H. (2021). Beneficial effects of green tea catechins on female reproductive disorders: A review. Molecules26, 2675. 10.3390/molecules26092675

  • CrossRef
  • Google Scholar

• 153

  KanfiY.NaimanS.AmirG.PeshtiV.ZinmanG.NahumL.et al (2012). The sirtuin SIRT6 regulates lifespan in male mice. Nature483, 218–221. 10.1038/nature10815

  • CrossRef
  • Google Scholar

• 154

  KanfiY.PeshtiV.GozlanY. M.RathausM.GilR.CohenH. Y. (2008). Regulation of SIRT1 protein levels by nutrient availability. FEBS Lett.582, 2417–2423. 10.1016/j.febslet.2008.06.005

  • CrossRef
  • Google Scholar

• 155

  KangH. L.BenzerS.MinK. T. (2002). Life extension in Drosophila by feeding a drug. Proc. Natl. Acad. Sci. U. S. A.99, 838–843. 10.1073/pnas.022631999

  • CrossRef
  • Google Scholar

• 156

  KaushikS.CuervoA. M. (2015). Proteostasis and aging. Nat. Med.21, 1406–1415. 10.1038/nm.4001

  • CrossRef
  • Google Scholar

• 157

  KavalipatiN.ShahJ.RamakrishanA.VasnawalaH. (2015). Pleiotropic effects of statins. Indian J. Endocrinol. Metab.19, 554–562. 10.4103/2230-8210.163106

  • CrossRef
  • Google Scholar

• 158

  KedlianV. R.DonertasH. M.ThorntonJ. M. (2019). The widespread increase in inter-individual variability of gene expression in the human brain with age. Aging (Albany NY)11, 2253–2280. 10.18632/aging.101912

  • CrossRef
  • Google Scholar

• 159

  KenigA.IlanY. (2019). A personalized signature and chronotherapy-based platform for improving the efficacy of sepsis treatment. Front. Physiol.10, 1542. 10.3389/fphys.2019.01542

  • CrossRef
  • Google Scholar

• 160

  KenigA.KolbenY.AslehR.AmirO.IlanY. (2021). Improving diuretic response in heart failure by implementing a patient-tailored variability and chronotherapy-guided algorithm. Front. Cardiovasc. Med.8, 695547. 10.3389/fcvm.2021.695547

  • CrossRef
  • Google Scholar

• 161

  KennedyB. K.BergerS. L.BrunetA.CampisiJ.CuervoA. M.EpelE. S.et al (2014). Geroscience: Linking aging to chronic disease. Cell.159, 709–713. 10.1016/j.cell.2014.10.039

  • CrossRef
  • Google Scholar

• 162

  KennedyB. K.LammingD. W. (2016). The mechanistic target of rapamycin: The grand ConducTOR of metabolism and aging. Cell. Metab.23, 990–1003. 10.1016/j.cmet.2016.05.009

  • CrossRef
  • Google Scholar

• 163

  KesslerA.Weksler-ZangenS.IlanY. (2020). Role of the immune system and the circadian rhythm in the pathogenesis of chronic pancreatitis: Establishing a personalized signature for improving the effect of immunotherapies for chronic pancreatitis. Pancreas49, 1024–1032. 10.1097/MPA.0000000000001626

  • CrossRef
  • Google Scholar

• 164

  KhanS. S.SingerB. D.VaughanD. E. (2017). Molecular and physiological manifestations and measurement of aging in humans. Aging Cell.16, 624–633. 10.1111/acel.12601

  • CrossRef
  • Google Scholar

• 165

  KhouryT.IlanY. (2019). Introducing patterns of variability for overcoming compensatory adaptation of the immune system to immunomodulatory agents: A novel method for improving clinical response to anti-TNF therapies. Front. Immunol.10, 2726. 10.3389/fimmu.2019.02726

  • CrossRef
  • Google Scholar

• 166

  KhouryT.IlanY. (2021). Platform introducing individually tailored variability in nerve stimulations and dietary regimen to prevent weight regain following weight loss in patients with obesity. Obes. Res. Clin. Pract.15, 114–123. 10.1016/j.orcp.2021.02.003

  • CrossRef
  • Google Scholar

• 167

  KimJ. Y.BaruaS.JeongY. J.LeeJ. E. (2020). Adiponectin: The potential regulator and therapeutic target of obesity and Alzheimer's disease. Int. J. Mol. Sci.21, E6419. 10.3390/ijms21176419

  • CrossRef
  • Google Scholar

• 168

  KimW.LudlowA. T.MinJ.RobinJ. D.StadlerG.MenderI.et al (2016). Regulation of the human telomerase gene TERT by telomere position effect-over long distances (TPE-OLD): Implications for aging and cancer. PLoS Biol.14, e2000016. 10.1371/journal.pbio.2000016

  • CrossRef
  • Google Scholar

• 169

  KimmelJ. C.PenlandL.RubinsteinN. D.HendricksonD. G.KelleyD. R.RosenthalA. Z. (2019). Murine single-cell RNA-seq reveals cell-identity- and tissue-specific trajectories of aging. Genome Res.29, 2088–2103. 10.1101/gr.253880.119

  • CrossRef
  • Google Scholar

• 170

  KingstonA.WohlandP.WittenbergR.RobinsonL.BrayneC.MatthewsF. E.et al (2017). Is late-life dependency increasing or not? A comparison of the cognitive function and ageing studies (cfas). Lancet390, 1676–1684. 10.1016/S0140-6736(17)31575-1

  • CrossRef
  • Google Scholar

• 171

  KioussisB.TuttleC. S. L.HeardD. S.KennedyB. K.LautenschlagerN. T.MaierA. B. (2021). Targeting impaired nutrient sensing with repurposed therapeutics to prevent or treat age-related cognitive decline and dementia: A systematic review. Ageing Res. Rev.67, 101302. 10.1016/j.arr.2021.101302

  • CrossRef
  • Google Scholar

• 172

  KirkwoodT. B. L. (2005). Understanding the odd science of aging. Cell.120, 437–447. 10.1016/j.cell.2005.01.027

  • CrossRef
  • Google Scholar

• 173

  KlaipsC. L.JayarajG. G.HartlF. U. (2017). Pathways of cellular proteostasis in aging and disease. J. Cell. Biol.217, 51–63. 10.1083/jcb.201709072

  • CrossRef
  • Google Scholar

• 174

  KlimovaB.NovotnyM.KucaK. (2018). Anti-aging drugs - prospect of longer life?Curr. Med. Chem.25, 1946–1953. 10.2174/0929867325666171129215251

  • CrossRef
  • Google Scholar

• 175

  KnightS. P.NewmanL.O'ConnorJ. D.DavisJ.KennyR. A.Romero-OrtunoR. (2020). Associations between neurocardiovascular signal entropy and physical frailty. Entropy (Basel)23, E4. 10.3390/e23010004

  • CrossRef
  • Google Scholar

• 176

  KolbenY.Weksler-ZangenS.IlanY. (2021). Adropin as a potential mediator of the metabolic system-autonomic nervous system-chronobiology axis: Implementing a personalized signature-based platform for chronotherapy. Obes. Rev.22, e13108. 10.1111/obr.13108

  • CrossRef
  • Google Scholar

• 177

  KounatidisI.ChtarbanovaS.CaoY.HayneM.JayanthD.GanetzkyB.et al (2017). NF-κB immunity in the brain determines fly lifespan in healthy aging and age-related neurodegeneration. Cell. Rep.19, 836–848. 10.1016/j.celrep.2017.04.007

  • CrossRef
  • Google Scholar

• 178

  KoutouroushisC.SarkarO. (2021). Role of autophagy in cardiovascular disease and aging. Cureus13, e20042. 10.7759/cureus.20042

  • CrossRef
  • Google Scholar

• 179

  KovacsZ.BrunnerB.AriC. (2021). Beneficial effects of exogenous ketogenic supplements on aging processes and age-related neurodegenerative diseases. Nutrients13, 2197. 10.3390/nu13072197

  • CrossRef
  • Google Scholar

• 180

  KraigE.LinehanL. A.LiangH.RomoT. Q.LiuQ.WuY.et al (2018). A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects. Exp. Gerontol.105, 53–69. 10.1016/j.exger.2017.12.026

  • CrossRef
  • Google Scholar

• 181

  KyriazisM. (1991). Applications of chaos theory to the molecular biology of aging. Exp. Gerontol.26, 569–572. 10.1016/0531-5565(91)90074-v

  • CrossRef
  • Google Scholar

• 182

  KyriazisM. (2003). Practical applications of chaos theory to the modulation of human ageing: Nature prefers chaos to regularity. Biogerontology4, 75–90. 10.1023/a:1023306419861

  • CrossRef
  • Google Scholar

• 183

  LaplanteM.SabatiniD. M. (2012). mTOR signaling in growth control and disease. Cell.149, 274–293. 10.1016/j.cell.2012.03.017

  • CrossRef
  • Google Scholar

• 184

  LaRoccaT. J.Gioscia-RyanR. A.HearonC. M.Jr.SealsD. R. (2013). The autophagy enhancer spermidine reverses arterial aging. Mech. Ageing Dev.134, 314–320. 10.1016/j.mad.2013.04.004

  • CrossRef
  • Google Scholar

• 185

  Larson-MeyerD. E.RedmanL.HeilbronnL. K.MartinC. K.RavussinE. (2010). Caloric restriction with or without exercise: The fitness versus fatness debate. Med. Sci. Sports Exerc.42, 152–159. 10.1249/MSS.0b013e3181ad7f17

  • CrossRef
  • Google Scholar

• 186

  LaszczykA. M.Fox-QuickS.VoH. T.NettlesD.PughP. C.Overstreet-WadicheL.et al (2017). Klotho regulates postnatal neurogenesis and protects against age-related spatial memory loss. Neurobiol. Aging59, 41–54. 10.1016/j.neurobiolaging.2017.07.008

  • CrossRef
  • Google Scholar

• 187

  LatifovicL.PeacockS. D.MasseyT. E.KingW. D. (2016). The influence of alcohol consumption, cigarette smoking, and physical activity on leukocyte telomere length. Cancer Epidemiol. Biomarkers Prev.25, 374–380. 10.1158/1055-9965.EPI-14-1364

  • CrossRef
  • Google Scholar

• 188

  LeeH-S.LeeM-J.KimH.ChoiS-K.KimJ-E.MoonH-I.et al (2010a). Curcumin inhibits TNFalpha-induced lectin-like oxidised LDL receptor-1 (LOX-1) expression and suppresses the inflammatory response in human umbilical vein endothelial cells (HUVECs) by an antioxidant mechanism. J. Enzyme Inhib. Med. Chem.25, 720–729. 10.3109/14756360903555274

  • CrossRef
  • Google Scholar

• 189

  LeeJ. C.KinniryP. A.ArguiriE.SerotaM.KanterakisS.ChatterjeeS.et al (2010b). Dietary curcumin increases antioxidant defenses in lung, ameliorates radiation-induced pulmonary fibrosis, and improves survival in mice. Radiat. Res.173, 590–601. 10.1667/RR1522.1

  • CrossRef
  • Google Scholar

• 190

  LeeK-S.LeeB-S.SemnaniS.AvanesianA.UmC-YJeonH-J.et al (2010c). Curcumin extends life span, improves health span, and modulates the expression of age-associated aging genes in Drosophila melanogaster. Rejuvenation Res.13, 561–570. 10.1089/rej.2010.1031

  • CrossRef
  • Google Scholar

• 191

  LeeW. S.KimJ. (2018). Insulin-like growth factor-1 signaling in cardiac aging. Biochim. Biophys. Acta. Mol. Basis Dis.1864, 1931–1938. 10.1016/j.bbadis.2017.08.029

  • CrossRef
  • Google Scholar

• 192

  LeeY. K.MazzuccoS.RothwellP. M.PayneS. J.WebbA. J. S. (2022). Blood pressure complexity discriminates pathological beat-to-beat variability as a marker of vascular aging. J. Am. Heart Assoc.11, e022865. 10.1161/JAHA.121.022865

  • CrossRef
  • Google Scholar

• 193

  LemoineM. (2021). The evolution of the hallmarks of aging. Front. Genet.12, 693071. 10.3389/fgene.2021.693071

  • CrossRef
  • Google Scholar

• 194

  LeontievaO. V.BlagosklonnyM. V. (2017). While reinforcing cell cycle arrest, rapamycin and Torins suppress senescence in UVA-irradiated fibroblasts. Oncotarget8, 109848–109856. 10.18632/oncotarget.17827

  • CrossRef
  • Google Scholar

• 195

  LiP.MaY.YuC.WuS.WangK.YiH.et al (2021). Autophagy and aging: Roles in skeletal muscle, eye, brain and hepatic tissue. Front. Cell. Dev. Biol.9, 752962. 10.3389/fcell.2021.752962

  • CrossRef
  • Google Scholar

• 196

  LinW. S.ChenJ. Y.WangJ. C.ChenL. Y.LinC. H.HsiehT. R.et al (2014). The anti-aging effects of Ludwigia octovalvis on Drosophila melanogaster and SAMP8 mice. Age (Dordr)36, 689–703. 10.1007/s11357-013-9606-z

  • CrossRef
  • Google Scholar

• 197

  LipsitzL. A.GoldbergerA. L. (1992). Loss of 'complexity' and aging. Potential applications of fractals and chaos theory to senescence. JAMA267, 1806–1809. 10.1001/jama.1992.03480130122036

  • CrossRef
  • Google Scholar

• 198

  LiuJ-K. (2022). Antiaging agents: Safe interventions to slow aging and healthy life span extension. Nat. Prod. Bioprospect.12, 18. 10.1007/s13659-022-00339-y

  • CrossRef
  • Google Scholar

• 199

  LiuL.TrimarchiJ. R.SmithP. J.KeefeD. L. (2002). Mitochondrial dysfunction leads to telomere attrition and genomic instability. Aging Cell.1, 40–46. 10.1046/j.1474-9728.2002.00004.x

  • CrossRef
  • Google Scholar

• 200

  LongoG.MontévilM.PochevilleA. (2012). From bottom-up approaches to levels of organization and extended critical transitions. Front. Physiol.3, 232. 10.3389/fphys.2012.00232

  • CrossRef
  • Google Scholar

• 201

  LoosB.EngelbrechtA. M.LockshinR. A.KlionskyD. J.ZakeriZ. (2013). The variability of autophagy and cell death susceptibility: Unanswered questions. Autophagy9, 1270–1285. 10.4161/auto.25560

  • CrossRef
  • Google Scholar

• 202

  López-OtínC.BlascoM. A.PartridgeL.SerranoM.KroemerG. (2013). The hallmarks of aging. Cell.153, 1194–1217. 10.1016/j.cell.2013.05.039

  • CrossRef
  • Google Scholar

• 203

  LowskyD. J.OlshanskyS. J.BhattacharyaJ.GoldmanD. P. (2014). Heterogeneity in healthy aging. J. Gerontol. A Biol. Sci. Med. Sci.69, 640–649. 10.1093/gerona/glt162

  • CrossRef
  • Google Scholar

• 204

  MaY.TullyP. J.HofmanA.TzourioC. (2020). Blood pressure variability and dementia: A state-of-the-art review. Am. J. Hypertens.33, 1059–1066. 10.1093/ajh/hpaa119

  • CrossRef
  • Google Scholar

• 205

  MadeoF.Carmona-GutierrezD.HoferS. J.KroemerG. (2019). Caloric restriction mimetics against age-associated disease: Targets, mechanisms, and therapeutic potential. Cell. Metab.29, 592–610. 10.1016/j.cmet.2019.01.018

  • CrossRef
  • Google Scholar

• 206

  MalekiM.KhelghatiN.AlemiF.BazdarM.AsemiZ.MajidiniaM.et al (2020). Stabilization of telomere by the antioxidant property of polyphenols: Anti-aging potential. Life Sci.259, 118341. 10.1016/j.lfs.2020.118341

  • CrossRef
  • Google Scholar

• 207

  MaresovaP.JavanmardiE.BarakovicS.Barakovic HusicJ.TomsoneS.KrejcarO.et al (2019). Consequences of chronic diseases and other limitations associated with old age – A scoping review. BMC Public Health19, 1431. 10.1186/s12889-019-7762-5

  • CrossRef
  • Google Scholar

• 208

  MartelJ.ChangS-H.WuC-Y.PengH. H.HwangT. L.KoY. F.et al (2021). Recent advances in the field of caloric restriction mimetics and anti-aging molecules. Ageing Res. Rev.66, 101240. 10.1016/j.arr.2020.101240

  • CrossRef
  • Google Scholar

• 209

  MartinetW.De LoofH.De MeyerG. R. Y. (2014). mTOR inhibition: a promising strategy for stabilization of atherosclerotic plaques. Atherosclerosis233, 601–607. 10.1016/j.atherosclerosis.2014.01.040

  • CrossRef
  • Google Scholar

• 210

  Martinez-JimenezC. P.ElingN.ChenH. C.VallejosC. A.KolodziejczykA. A.ConnorF.et al (2017). Aging increases cell-to-cell transcriptional variability upon immune stimulation. Science355, 1433–1436. 10.1126/science.aah4115

  • CrossRef
  • Google Scholar

• 211

  Martinez-MoralM-P.KannanK. (2019). How stable is oxidative stress level? An observational study of intra- and inter-individual variability in urinary oxidative stress biomarkers of DNA, proteins, and lipids in healthy individuals. Environ. Int.123, 382–389. 10.1016/j.envint.2018.12.009

  • CrossRef
  • Google Scholar

• 212

  MaxwellF.McGlynnL. M.MuirH. C.TalwarD.BenzevalM.RobertsonT.et al (2011). Telomere attrition and decreased fetuin-A levels indicate accelerated biological aging and are implicated in the pathogenesis of colorectal cancer. Clin. Cancer Res.17, 5573–5581. 10.1158/1078-0432.CCR-10-3271

  • CrossRef
  • Google Scholar

• 213

  McCollG.KillileaD. W.HubbardA. E.VantipalliM. C.MelovS.LithgowG. J. (2008). Pharmacogenetic analysis of lithium-induced delayed aging in Caenorhabditis elegans. J. Biol. Chem.283, 350–357. 10.1074/jbc.M705028200

  • CrossRef
  • Google Scholar

• 214

  McLachlanA. J.HilmerS. N.Le CouteurD. G. (2009). Variability in response to medicines in older people: Phenotypic and genotypic factors. Clin. Pharmacol. Ther.85, 431–433. 10.1038/clpt.2009.1

  • CrossRef
  • Google Scholar

• 215

  McPheeJ. S.FrenchD. P.JacksonD.NazrooJ.PendletonN.DegensH. (2016). Physical activity in older age: Perspectives for healthy ageing and frailty. Biogerontology17, 567–580. 10.1007/s10522-016-9641-0

  • CrossRef
  • Google Scholar

• 216

  Melo PereiraS.RibeiroR.LogarinhoE. (2019). Approaches towards longevity: Reprogramming, senolysis, and improved mitotic competence as anti-aging therapies. Int. J. Mol. Sci.20, E938. 10.3390/ijms20040938

  • CrossRef
  • Google Scholar

• 217

  MendenhallA. R.MartinG. M.KaeberleinM.AndersonR. M. (2021). Cell-to-cell variation in gene expression and the aging process. GeroScience43, 181–196. 10.1007/s11357-021-00339-9

  • CrossRef
  • Google Scholar

• 218

  MicoV.BerninchesL.TapiaJ.DaimielL. (2017). NutrimiRAging: Micromanaging nutrient sensing pathways through nutrition to promote healthy aging. Int. J. Mol. Sci.18, E915. 10.3390/ijms18050915

  • CrossRef
  • Google Scholar

• 219

  MillerL. E.LehtorantaL.LehtinenM. J. (2019). Short-term probiotic supplementation enhances cellular immune function in healthy elderly: Systematic review and meta-analysis of controlled studies. Nutr. Res.64, 1–8. 10.1016/j.nutres.2018.12.011

  • CrossRef
  • Google Scholar

• 220

  MiquelJ.FlemingJ.EconomosA. C. (1982). Antioxidants, metabolic rate and aging in Drosophila. Arch. Gerontol. Geriatr.1, 159–165. 10.1016/0167-4943(82)90016-4

  • CrossRef
  • Google Scholar

• 221

  MisawaT.TanakaY.OkadaR.TakahashiA. (2020). Biology of extracellular vesicles secreted from senescent cells as senescence-associated secretory phenotype factors. Geriatr. Gerontol. Int.20, 539–546. 10.1111/ggi.13928

  • CrossRef
  • Google Scholar

• 222

  MitchellS. J.BernierM.MattisonJ. A.AonM. A.KaiserT. A.AnsonR. M.et al (2019). Daily fasting improves health and survival in male mice independent of diet composition and calories. Cell. Metab.29, 221–228. e3. 10.1016/j.cmet.2018.08.011

  • CrossRef
  • Google Scholar

• 223

  MitchisonT.KirschnerM. (1984). Dynamic instability of microtubule growth. Nature312, 237–242. 10.1038/312237a0

  • CrossRef
  • Google Scholar

• 224

  MitnitskiA.HowlettS. E.RockwoodK. (2017). Heterogeneity of human aging and its assessment. J. Gerontol. A Biol. Sci. Med. Sci.72, 877–884. 10.1093/gerona/glw089

  • CrossRef
  • Google Scholar

• 225

  MohammedI.HollenbergM. D.DingH.TriggleC. R. (2021). A critical review of the evidence that metformin is a putative anti-aging drug that enhances healthspan and extends lifespan. Front. Endocrinol.12, 718942. 10.3389/fendo.2021.718942

  • CrossRef
  • Google Scholar

• 226

  MostJ.GilmoreL. A.SmithS. R.HanH.RavussinE.RedmanL. M. (2018). Significant improvement in cardiometabolic health in healthy nonobese individuals during caloric restriction-induced weight loss and weight loss maintenance. Am. J. Physiol. Endocrinol. Metab.314, E396-E405–E405. 10.1152/ajpendo.00261.2017

  • CrossRef
  • Google Scholar

• 227

  MostoslavskyR.ChuaK. F.LombardD. B.PangW. W.FischerM. R.GellonL.et al (2006). Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell.124, 315–329. 10.1016/j.cell.2005.11.044

  • CrossRef
  • Google Scholar

• 228

  Motamed-JahromiM.KavehM. H. (2020). Effective interventions on improving elderly's independence in activity of daily living: A systematic review and logic model. Front. Public Health8, 516151. 10.3389/fpubh.2020.516151

  • CrossRef
  • Google Scholar

• 229

  MusumeciG.CastrogiovanniP.SzychlinskaM. A.ImbesiR.LoretoC.CastorinaS.et al (2017). Protective effects of high Tryptophan diet on aging-induced passive avoidance impairment and hippocampal apoptosis. Brain Res. Bull.128, 76–82. 10.1016/j.brainresbull.2016.11.007

  • CrossRef
  • Google Scholar

• 230

  MuzammilA.WaqasM.UmarA.SufyanM.RehmanA.HaiderA.et al (2021). Anti-aging natural compounds and their role in the regulation of metabolic pathways leading to longevity. Mini Rev. Med. Chem.21, 2630–2656. 10.2174/1389557521666210405162006

  • CrossRef
  • Google Scholar

• 231

  NaciH.BrugtsJ. J.FleurenceR.AdesA. E. (2013). Comparative effects of statins on major cerebrovascular events: A multiple-treatments meta-analysis of placebo-controlled and active-comparator trials. QJM106, 299–306. 10.1093/qjmed/hct041

  • CrossRef
  • Google Scholar

• 232

  NematiS.EdwardsB. A.LeeJ.Pittman-PollettaB.ButlerJ. P.MalhotraA. (2013). Respiration and heart rate complexity: Effects of age and gender assessed by band-limited transfer entropy. Respir. Physiol. Neurobiol.189, 27–33. 10.1016/j.resp.2013.06.016

  • CrossRef
  • Google Scholar

• 233

  NeupertS. D.ZhuX. (2020). Heterogeneity in aging: The need for A tripartite contextual approach. Gerontologist61, 132–133. 10.1093/geront/gnaa127

  • CrossRef
  • Google Scholar

• 234

  NevesJ.Sousa-VictorP. (2020). Regulation of inflammation as an anti-aging intervention. FEBS J.287, 43–52. 10.1111/febs.15061

  • CrossRef
  • Google Scholar

• 235

  NewmanJ. C.VerdinE. (2017). β-Hydroxybutyrate: A signaling metabolite. Annu. Rev. Nutr.37, 51–76. 10.1146/annurev-nutr-071816-064916

  • CrossRef
  • Google Scholar

• 236

  NgT. P.FengL.YapK. B.LeeT. S.TanC. H.WinbladB. (2014). Long-term metformin usage and cognitive function among older adults with diabetes. J. Alzheimers Dis.41, 61–68. 10.3233/JAD-131901

  • CrossRef
  • Google Scholar

• 237

  NguyenQ. D.MoodieE. M.ForgetM. F.DesmaraisP.KeezerM. R.WolfsonC. (2021). Health heterogeneity in older adults: Exploration in the Canadian longitudinal study on aging. J. Am. Geriatr. Soc.69, 678–687. 10.1111/jgs.16919

  • CrossRef
  • Google Scholar

• 238

  NicoliniP.CiullaM. M.De AsmundisC.MagriniF.BrugadaP. (2012). The prognostic value of heart rate variability in the elderly, changing the perspective: From sympathovagal balance to chaos theory. Pacing Clin. Electrophysiol.35, 622–638. 10.1111/j.1540-8159.2012.03335.x

  • CrossRef
  • Google Scholar

• 239

  NiedernhoferL. J.GurkarA. U.WangY.VijgJ.HoeijmakersJ. H. J.RobbinsP. D. (2018). Nuclear genomic instability and aging. Annu. Rev. Biochem.87, 295–322. 10.1146/annurev-biochem-062917-012239

  • CrossRef
  • Google Scholar

• 240

  NiedernhoferL. J.RobbinsP. D. (2008). Signaling mechanisms involved in the response to genotoxic stress and regulating lifespan. Int. J. Biochem. Cell. Biol.40, 176–180. 10.1016/j.biocel.2007.10.008

  • CrossRef
  • Google Scholar

• 241

  NilholmC.RothB.HoglundP.BlennowK.EnglundE.HanssonO.et al (2018). Dietary intervention with an Okinawan-based Nordic diet in type 2 diabetes renders decreased interleukin-18 concentrations and increased neurofilament light concentrations in plasma. Nutr. Res.60, 13–25. 10.1016/j.nutres.2018.08.002

  • CrossRef
  • Google Scholar

• 242

  O'HaganC.LiJ. V.MarchesiJ. R.PlummerS.GaraiovaI.GoodM. A. (2017). Long-term multi-species Lactobacillus and Bifidobacterium dietary supplement enhances memory and changes regional brain metabolites in middle-aged rats. Neurobiol. Learn. Mem.144, 36–47. 10.1016/j.nlm.2017.05.015

  • CrossRef
  • Google Scholar

• 243

  OesterleA.LaufsU.LiaoJ. K. (2017). Pleiotropic effects of statins on the cardiovascular system. Circ. Res.120, 229–243. 10.1161/CIRCRESAHA.116.308537

  • CrossRef
  • Google Scholar

• 244

  OgliariG.SmitR. A.WestendorpR. G.JukemaJ. W.de CraenA. J. M.SabayanB. (2016). Visit-to-visit blood pressure variability and future functional decline in old age. J. Hypertens.34, 1544–1550. 10.1097/HJH.0000000000000979

  • CrossRef
  • Google Scholar

• 245

  OgrodnikM.MiwaS.TchkoniaT.TiniakosD.WilsonC. L.LahatA.et al (2017). Cellular senescence drives age-dependent hepatic steatosis. Nat. Commun.8, 15691–15712. 10.1038/ncomms15691

  • CrossRef
  • Google Scholar

• 246

  OhJ.LeeY. D.WagersA. J. (2014). Stem cell aging: Mechanisms, regulators and therapeutic opportunities. Nat. Med.20, 870–880. 10.1038/nm.3651

  • CrossRef
  • Google Scholar

• 247

  OmotoA. C. M.LataroR. M.SilvaT. M.SalgadoH. C.FazanR.JrSilvaL. E. V. (2021). Heart rate fragmentation, a novel approach in heart rate variability analysis, is altered in rats 4 and 12 weeks after myocardial infarction. Med. Biol. Eng. Comput.59, 2373–2382. 10.1007/s11517-021-02441-8

  • CrossRef
  • Google Scholar

• 248

  OxenkrugG.NavrotskayaV.VorobyovaL.SummergradP. (2012). Minocycline effect on life and health span of Drosophila melanogaster. Aging Dis.3, 352–359.

  • Google Scholar

• 249

  PanwarP.LamourG.MackenzieN. C.YangH.KoF.LiH.et al (2015). Changes in structural-mechanical properties and degradability of collagen during aging-associated modifications. J. Biol. Chem.290, 23291–23306. 10.1074/jbc.M115.644310

  • CrossRef
  • Google Scholar

• 250

  PapadopoliD.BoulayK.KazakL.PollakM.MalletteF. A.TopisirovicI.et al (2019). mTOR as a central regulator of lifespan and aging, 8, F1000Res.

  • Google Scholar

• 251

  PapanagnouP.StivarouT.PapageorgiouI.PapadopoulosG. E.PappasA. (2017). Marketed drugs used for the management of hypercholesterolemia as anticancer armament. Onco. Targets. Ther.10, 4393–4411. 10.2147/OTT.S140483

  • CrossRef
  • Google Scholar

• 252

  PasyukovaE. G.VaisermanA. M. (2017). HDAC inhibitors: A new promising drug class in anti-aging research. Mech. Ageing Dev.166, 6–15. 10.1016/j.mad.2017.08.008

  • CrossRef
  • Google Scholar

• 253

  PellestorF.GaillardJ. B.SchneiderA.PuechbertyJ.GatinoisV. (2021). Chromoanagenesis, the mechanisms of a genomic chaos. Semin. Cell. Dev. Biol.123, 90–99. 10.1016/j.semcdb.2021.01.004

  • CrossRef
  • Google Scholar

• 254

  PietschK.SaulN.MenzelR.SturzenbaumS. R.SteinbergC. E. W. (2009). Quercetin mediated lifespan extension in Caenorhabditis elegans is modulated by age-1, daf-2, sek-1 and unc-43. Biogerontology10, 565–578. 10.1007/s10522-008-9199-6

  • CrossRef
  • Google Scholar

• 255

  PikkujamsaS. M.MakikallioT. H.SouranderL. B.RaihaI. J.PuukkaP.SkyttaJ.et al (1999). Cardiac interbeat interval dynamics from childhood to senescence : Comparison of conventional and new measures based on fractals and chaos theory. Circulation100, 393–399. 10.1161/01.cir.100.4.393

  • CrossRef
  • Google Scholar

• 256

  PiskovatskaV.StrilbytskaO.KoliadaA.VaisermanA.LushchakO. (2019). Health benefits of anti-aging drugs. Subcell. Biochem.91, 339–392. 10.1007/978-981-13-3681-2_13

  • CrossRef
  • Google Scholar

• 257

  PooleJ. C.ThainA.PerkinsN. D.RoninsonI. B. (2004). Induction of transcription by p21Waf1/cip1/sdi1: Role of NFkappaB and effect of non-steroidal anti-inflammatory drugs. Cell. Cycle3, 931–940.

  • Google Scholar

• 258

  PotruchA.KhouryS. T.IlanY. (2020). The role of chronobiology in drug-resistance epilepsy: The potential use of a variability and chronotherapy-based individualized platform for improving the response to anti-seizure drugs. Seizure80, 201–211. 10.1016/j.seizure.2020.06.032

  • CrossRef
  • Google Scholar

• 259

  PromislowD. E. L. (1994). DNA repair and the evolution of longevity: A critical analysis. J. Theor. Biol.170, 291–300. 10.1006/jtbi.1994.1190

  • CrossRef
  • Google Scholar

• 260

  RaichlenD. A.KlimentidisY. C.HsuC. H.AlexanderG. E. (2019). Fractal complexity of daily physical activity patterns differs with age over the life span and is associated with mortality in older adults. J. Gerontol. A Biol. Sci. Med. Sci.74, 1461–1467. 10.1093/gerona/gly247

  • CrossRef
  • Google Scholar

• 261

  RajuN.Sobieraj-TeagueM.BoschJ.EikelboomJ. W. (2016). Updated meta-analysis of aspirin in primary prevention of cardiovascular disease. Am. J. Med.129, e35–e36. 10.1016/j.amjmed.2015.10.046

  • CrossRef
  • Google Scholar

• 262

  RamanD.KaffashiF.LuiL. Y.SauerW. H.RedlineS.StoneP.et al (2017). Polysomnographic heart rate variability indices and atrial ectopy associated with incident atrial fibrillation risk in older community-dwelling men. JACC. Clin. Electrophysiol.3, 451–460. 10.1016/j.jacep.2016.09.001

  • CrossRef
  • Google Scholar

• 263

  RibeiroA. R.HowlettS. E.FernandesA. (2020). Frailty-A promising concept to evaluate disease vulnerability. Mech. Ageing Dev.187, 111217. 10.1016/j.mad.2020.111217

  • CrossRef
  • Google Scholar

• 264

  RingA.KimY. M.KahnM. (2014). Wnt/catenin signaling in adult stem cell physiology and disease. Stem Cell. Rev. Rep.10, 512–525. 10.1007/s12015-014-9515-2

  • CrossRef
  • Google Scholar

• 265

  RobertsM. N.WallaceM. A.TomilovA. A.ZhouZ.MarcotteG. R.TranD.et al (2018). A ketogenic diet extends longevity and healthspan in adult mice. Cell. Metab.27, 1156. 10.1016/j.cmet.2018.04.005

  • CrossRef
  • Google Scholar

• 266

  RobertsS. B.RosenbergI. (2006). Nutrition and aging: Changes in the regulation of energy metabolism with aging. Physiol. Rev.86, 651–667. 10.1152/physrev.00019.2005

  • CrossRef
  • Google Scholar

• 267

  RochonJ.BalesC. W.RavussinE.RedmanL. M.HolloszyJ. O.RacetteS. B.et al (2011). Design and conduct of the CALERIE study: Comprehensive assessment of the long-term effects of reducing intake of energy. J. Gerontol. A Biol. Sci. Med. Sci.66, 97–108. 10.1093/gerona/glq168

  • CrossRef
  • Google Scholar

• 268

  RosM.CarrascosaJ. M. (2020). Current nutritional and pharmacological anti-aging interventions. Biochim. Biophys. Acta. Mol. Basis Dis.1866, 165612. 10.1016/j.bbadis.2019.165612

  • CrossRef
  • Google Scholar

• 269

  RoseG.DatoS.AltomareK.BellizziD.GaraStoS.GrecoV.et al (2003). Variability of the SIRT3 gene, human silent information regulator Sir2 homologue, and survivorship in the elderly. Exp. Gerontol.38, 1065–1070. 10.1016/s0531-5565(03)00209-2

  • CrossRef
  • Google Scholar

• 270

  RuzankinaY.BrownE. J. (2007). Relationships between stem cell exhaustion, tumour suppression and ageing. Br. J. Cancer97, 1189–1193. 10.1038/sj.bjc.6604029

  • CrossRef
  • Google Scholar

• 271

  SahinE.CollaS.LiesaM.MoslehiJ.MullerF. L.GuoM.et al (2011). Telomere dysfunction induces metabolic and mitochondrial compromise. Nature470, 359–365. 10.1038/nature09787

  • CrossRef
  • Google Scholar

• 272

  SantoroA.MartucciM.ConteM.CapriM.FranceschiC.SalvioliS. (2020). Inflammaging, hormesis and the rationale for anti-aging strategies. Ageing Res. Rev.64, 101142. 10.1016/j.arr.2020.101142

  • CrossRef
  • Google Scholar

• 273

  SantraM.DillK. A.de GraffA. M. R. (2019). Proteostasis collapse is a driver of cell aging and death. Proc. Natl. Acad. Sci. U. S. A.116, 22173–22178. 10.1073/pnas.1906592116

  • CrossRef
  • Google Scholar

• 274

  SaraswatK.RizviS. I. (2017). Novel strategies for anti-aging drug discovery. Expert Opin. Drug Discov.12, 955–966. 10.1080/17460441.2017.1349750

  • CrossRef
  • Google Scholar

• 275

  SaxtonR. A.SabatiniD. M. (2017). mTOR signaling in growth, metabolism, and disease. Cell.168, 960–976. 10.1016/j.cell.2017.02.004

  • CrossRef
  • Google Scholar

• 276

  SchaferM. J.WhiteT. A.IijimaK.HaakA. J.LigrestiG.AtkinsonE. J.et al (2017). Cellular senescence mediates fibrotic pulmonary disease. Nat. Commun.8, 14532. 10.1038/ncomms14532

  • CrossRef
  • Google Scholar

• 277

  Schmauck-MedinaT.MolièreA.LautrupS.ZhangJ.ChlopickiS.MadsenH. B.et al (2022). New hallmarks of ageing: A 2022 copenhagen ageing meeting summary. Aging14, 6829–6839. 10.18632/aging.204248

  • CrossRef
  • Google Scholar

• 278

  SealsD. R.JablonskiK. L.DonatoA. J. (2011). Aging and vascular endothelial function in humans. Clin. Sci.120, 357–375. 10.1042/CS20100476

  • CrossRef
  • Google Scholar

• 279

  SellamiM.BragazziN.PrinceM. S.DenhamJ.ElrayessM. (2021). Regular, intense exercise training as a healthy aging lifestyle strategy: Preventing DNA damage, telomere shortening and adverse DNA methylation changes over a lifetime. Front. Genet.12, 652497. 10.3389/fgene.2021.652497

  • CrossRef
  • Google Scholar

• 280

  ShadelG. S.AdamsP. D.BerggrenW. T.DiedrichJ. K.DiffenderferK. E.GageF. H.et al (2021). The san diego nathan shock center: Tackling the heterogeneity of aging. Geroscience43, 2139–2148. 10.1007/s11357-021-00426-x

  • CrossRef
  • Google Scholar

• 281

  ShammiP.BosmanE.StussD. T. (1998). Aging and variability in performance. Aging, Neuropsychology, Cognition5, 1–13. 10.1076/anec.5.1.1.23

  • CrossRef
  • Google Scholar

• 282

  ShenL. R.ParnellL. D.OrdovasJ. M.LaiC. Q. (2013). Curcumin and aging. Biofactors39, 133–140. 10.1002/biof.1086

  • CrossRef
  • Google Scholar

• 283

  ShimobayashiM.HallM. N. (2014). Making new contacts: The mTOR network in metabolism and signalling crosstalk. Nat. Rev. Mol. Cell. Biol.15, 155–162. 10.1038/nrm3757

  • CrossRef
  • Google Scholar

• 284

  ShimomuraM.OyamaJ.TakeuchiM.ShibataY.YamamotoY.KawasakiT.et al (2016). Acute effects of statin on reduction of angiopoietin-like 2 and glyceraldehyde-derived advanced glycation end-products levels in patients with acute myocardial infarction: A message from SAMIT (statin for acute myocardial infarction trial). Heart Vessels31, 1583–1589. 10.1007/s00380-015-0773-y

  • CrossRef
  • Google Scholar

• 285

  ShuY.SheardownS. A.BrownC.OwenR. P.ZhangS.CastroR. A.et al (2007). Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J. Clin. Investig.117, 1422–1431. 10.1172/JCI30558

  • CrossRef
  • Google Scholar

• 286

  SiddiquiR.MaciverS.ElmoselhiA.SoaresN. C.KhanN. A. (2021). Longevity, cellular senescence and the gut microbiome: Lessons to be learned from crocodiles. Heliyon7, e08594. 10.1016/j.heliyon.2021.e08594

  • CrossRef
  • Google Scholar

• 287

  Sleimen-MalkounR.TempradoJ. J.HongS. L. (2014). Aging induced loss of complexity and dedifferentiation: Consequences for coordination dynamics within and between brain, muscular and behavioral levels. Front. Aging Neurosci.6, 140. 10.3389/fnagi.2014.00140

  • CrossRef
  • Google Scholar

• 288

  SotiC.CsermelyP.et al (2003). Aging and molecular chaperones. Exp. Gerontol.38 (10), 1037–1040. 10.1016/s0531-5565(03)00185-2

  • CrossRef
  • Google Scholar

• 289

  Solon-BietS. M.McMahonA. C.BallardJ. W. O.RuohonenK.WuL. E.CoggerV. C.et al (2014). The ratio of macronutrients, not caloric intake, dictates cardiometabolic health, aging, and longevity in ad libitum-fed mice. Cell. Metab.19, 418–430. 10.1016/j.cmet.2014.02.009

  • CrossRef
  • Google Scholar

• 290

  SonD-H.ParkW-J.LeeY-J. (2019). Recent advances in anti-aging medicine. Korean J. Fam. Med.40, 289–296. 10.4082/kjfm.19.0087

  • CrossRef
  • Google Scholar

• 291

  SoukasA. A.HaoH.WuL. (2019). Metformin as anti-aging therapy: Is it for everyone?Trends Endocrinol. Metab.30, 745–755. 10.1016/j.tem.2019.07.015

  • CrossRef
  • Google Scholar

• 292

  SpittauB. (2017). Aging microglia-phenotypes, functions and implications for age-related neurodegenerative diseases. Front. Aging Neurosci.9, 194. 10.3389/fnagi.2017.00194

  • CrossRef
  • Google Scholar

• 293

  StewartT. M.BhapkarM.DasS.GalanK.MartinC. K.McAdamsL.et al (2013). Comprehensive assessment of long-term effects of reducing intake of energy phase 2 (CALERIE phase 2) screening and recruitment: Methods and results. Contemp. Clin. Trials34, 10–20. 10.1016/j.cct.2012.08.011

  • CrossRef
  • Google Scholar

• 294

  StrongR.MillerR. A.AstleC. M.FloydR. A.FlurkeyK.HensleyK. L.et al (2008). Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice. Aging Cell.7, 641–650. 10.1111/j.1474-9726.2008.00414.x

  • CrossRef
  • Google Scholar

• 295

  SuckowB. K.SuckowM. A. (2006). Lifespan extension by the antioxidant curcumin in Drosophila melanogaster. Int. J. Biomed. Sci.2, 402–405.

  • Google Scholar

• 296

  ToosizadehN.EskandariM.EhsaniH.ParvanehS.AsghariM.SweitzerN.et al (2022). Frailty assessment using a novel approach based on combined motor and cardiac functions: a pilot study. BMC Geriatrics22, 199. 10.1186/s12877-022-02849-3

  • CrossRef
  • Google Scholar

• 297

  TejedorJ. R.FragaM. F. (2017). Interindividual epigenetic variability: Sound or noise?BioEssays39, 1700055. 10.1002/bies.201700055

  • CrossRef
  • Google Scholar

• 298

  TeodoriL.PetrignaniI.GiulianiA.PrattichizzoF.GurauF.MatacchioneG.et al (2019). Inflamm-aging microRNAs may integrate signals from food and gut microbiota by modulating common signalling pathways. Mech. Ageing Dev.182, 111127. 10.1016/j.mad.2019.111127

  • CrossRef
  • Google Scholar

• 299

  ThannickalV. J. (2013). Mechanistic links between aging and lung fibrosis. Biogerontology14, 609–615. 10.1007/s10522-013-9451-6

  • CrossRef
  • Google Scholar

• 300

  TinsleyG. M.La BountyP. M. (2015). Effects of intermittent fasting on body composition and clinical health markers in humans. Nutr. Rev.73, 661–674. 10.1093/nutrit/nuv041

  • CrossRef
  • Google Scholar

• 301

  TrainerP. J.DrakeW. M.KatznelsonL.FredaP. U.Herman-BonertV.van der LelyA. J.et al (2000). Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N. Engl. J. Med.342, 1171–1177. 10.1056/NEJM200004203421604

  • CrossRef
  • Google Scholar

• 302

  TulletJ. M.HertweckM.AnJ. H.BakerJ.HwangJ. Y.LiuS.et al (2008). Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans. Cell.132, 1025–1038. 10.1016/j.cell.2008.01.030

  • CrossRef
  • Google Scholar

• 303

  VaillantG. E.MukamalK. (2001). Successful aging. Am. J. Psychiatry158, 839–847. 10.1176/appi.ajp.158.6.839

  • CrossRef
  • Google Scholar

• 304

  VaisermanA. M.KoliadaA. K.MarottaF. (2017). Gut microbiota: A player in aging and a target for anti-aging intervention. Ageing Res. Rev.35, 36–45. 10.1016/j.arr.2017.01.001

  • CrossRef
  • Google Scholar

• 305

  van BeekA. A.HugenholtzF.MeijerB.SovranB.PerdijkO.VermeijW. P.et al (2017). Frontline Science: Tryptophan restriction arrests B cell development and enhances microbial diversity in WT and prematurely aging Ercc1-/Δ7 mice. J. Leukoc. Biol.101, 811–821. 10.1189/jlb.1HI0216-062RR

  • CrossRef
  • Google Scholar

• 306

  van DeursenJ. M. (2014). The role of senescent cells in ageing. Nature509, 439–446. 10.1038/nature13193

  • CrossRef
  • Google Scholar

• 307

  VeroneseN.StubbsB.MaggiS.ThompsonT.SchofieldP.MullerC.et al (2017). Low-dose aspirin use and cognitive function in older age: A systematic review and meta-analysis. J. Am. Geriatr. Soc.65, 1763–1768. 10.1111/jgs.14883

  • CrossRef
  • Google Scholar

• 308

  VijgJ.SuhY. (2013). Genome instability and aging. Annu. Rev. Physiol.75, 645–668. 10.1146/annurev-physiol-030212-183715

  • CrossRef
  • Google Scholar

• 309

  ViolaA. U.TobaldiniE.ChellappaS. L.CasaliK. R.PortaA.MontanoN. (2011). Short-term complexity of cardiac autonomic control during sleep: REM as a potential risk factor for cardiovascular system in aging. PLoS One6, e19002. 10.1371/journal.pone.0019002

  • CrossRef
  • Google Scholar

• 310

  VolobuevaA. S.MelnichenkoA. A.GrechkoA. V.OrekhovA. N. (2018). Mitochondrial genome variability: The effect on cellular functional activity. Ther. Clin. Risk Manag.14, 237–245. 10.2147/TCRM.S153895

  • CrossRef
  • Google Scholar

• 311

  von ZglinickiT. (2002). Oxidative stress shortens telomeres. Trends biochem. Sci.27, 339–344. 10.1016/s0968-0004(02)02110-2

  • CrossRef
  • Google Scholar

• 312

  VuksanovicV.GalV. (2005). Nonlinear and chaos characteristics of heart period time series: Healthy aging and postural change. Auton. Neurosci.121, 94–100. 10.1016/j.autneu.2005.06.004

  • CrossRef
  • Google Scholar

• 313

  WagnerK. H.Cameron-SmithD.WessnerB.FranzkeB. (2016). Biomarkers of aging: From function to molecular biology. Nutrients8, E338. 10.3390/nu8060338

  • CrossRef
  • Google Scholar

• 314

  WallisR.MizenH.BishopC. L. (2020). The bright and dark side of extracellular vesicles in the senescence-associated secretory phenotype. Mech. Ageing Dev.189, 111263. 10.1016/j.mad.2020.111263

  • CrossRef
  • Google Scholar

• 315

  WanQ. L.ZhengS. Q.WuG. S.LuoH. R. (2013). Aspirin extends the lifespan of Caenorhabditis elegans via AMPK and DAF-16/FOXO in dietary restriction pathway. Exp. Gerontol.48, 499–506. 10.1016/j.exger.2013.02.020

  • CrossRef
  • Google Scholar

• 316

  WangC.WheelerC. T.AlbericoT.SunX.SeebergerJ.LasloM.et al (2013). The effect of resveratrol on lifespan depends on both gender and dietary nutrient composition in Drosophila melanogaster. Age (Dordr)35, 69–81. 10.1007/s11357-011-9332-3

  • CrossRef
  • Google Scholar

• 317

  WangH. L.SunZ. O.RehmanR. U.WangY. F. (2017). Rosemary extract-mediated lifespan extension and attenuated oxidative damage in Drosophila melanogaster fed on high-fat diet. J. Food Sci.82, 1006–1011. 10.1111/1750-3841.13656

  • CrossRef
  • Google Scholar

• 318

  WangK.WuD.ZhangH.DasA.BasuM.MalinJ.et al (2018). Comprehensive map of age-associated splicing changes across human tissues and their contributions to age-associated diseases. Sci. Rep.8, 10929. 10.1038/s41598-018-29086-2

  • CrossRef
  • Google Scholar

• 319

  WangQ.ZhanY.PedersenN. L.FangF.HaggS. (2018). Telomere length and all-cause mortality: A meta-analysis. Ageing Res. Rev.48, 11–20. 10.1016/j.arr.2018.09.002

  • CrossRef
  • Google Scholar

• 320

  WangZ. (2020). Brain entropy mapping in healthy aging and Alzheimer's disease. Front. Aging Neurosci.12, 596122. 10.3389/fnagi.2020.596122

  • CrossRef
  • Google Scholar

• 321

  WatrobaM.SzukiewiczD. (2021). Sirtuins at the service of healthy longevity. Front. Physiol.12, 724506. 10.3389/fphys.2021.724506

  • CrossRef
  • Google Scholar

• 322

  WileyC. D.FlynnJ. M.MorrisseyC.LebofskyR.ShugaJ.DongX.et al (2017). Analysis of individual cells identifies cell-to-cell variability following induction of cellular senescence. Aging Cell.16, 1043–1050. 10.1111/acel.12632

  • CrossRef
  • Google Scholar

• 323

  WilliamsD. S.CashA.HamadaniL.DiemerT. (2009). Oxaloacetate supplementation increases lifespan in Caenorhabditis elegans through an AMPK/FOXO-dependent pathway. Aging Cell.8, 765–768. 10.1111/j.1474-9726.2009.00527.x

  • CrossRef
  • Google Scholar

• 324

  WilsonM. A.Shukitt-HaleB.KaltW.IngramD. K.JosephJ. A.WolkowC. A. (2006). Blueberry polyphenols increase lifespan and thermotolerance in Caenorhabditis elegans. Aging Cell.5, 59–68. 10.1111/j.1474-9726.2006.00192.x

  • CrossRef
  • Google Scholar

• 325

  WooJ.YuR.TsoiK.MengH. (2018). Variability in repeated blood pressure measurements as a marker of frailty. J. Nutr. Health Aging22, 1122–1127. 10.1007/s12603-018-1082-9

  • CrossRef
  • Google Scholar

• 326

  World Health Organization (2022). Ghe: Life expectancy and healthy life expectancy. Available at: https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-life-expectancy-and-healthy-life-expectancy (viewed 10, 22).

  • Google Scholar

• 327

  WuY. L.XuJ.RongX. Y.WangF.WangH. J.ZhaoC. (2021). Gut microbiota alterations and health status in aging adults: From correlation to causation. Aging Med.4, 206–213. 10.1002/agm2.12167

  • CrossRef
  • Google Scholar

• 328

  wustlWUSoMCGWEPRSBVDTFLS-Mkskbkshjojim.eduRacetteS. B.VillarealD. T.FontanaL.Steger-MayK.SchechtmanK. B.et al (2006). Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: A randomized controlled trial. Am. J. Clin. Nutr.84, 1033–1042. 10.1093/ajcn/84.5.1033

  • CrossRef
  • Google Scholar

• 329

  XiaoN. M.ZhangY. M.ZhengQ.GuJ. (2004). Klotho is a serum factor related to human aging. Chin. Med. J.117, 742–747.

  • Google Scholar

• 330

  XuK.GuoY.LiZ.WangZ. (2019). Aging biomarkers and novel targets for anti-aging interventions. Adv. Exp. Med. Biol.1178, 39–56. 10.1007/978-3-030-25650-0_3

  • CrossRef
  • Google Scholar

• 331

  XuM.PirtskhalavaT.FarrJ. N.WeigandB. M.PalmerA. K.WeivodaM. M.et al (2018). Senolytics improve physical function and increase lifespan in old age. Nat. Med.24, 1246–1256. 10.1038/s41591-018-0092-9

  • CrossRef
  • Google Scholar

• 332

  YabutaS.MasakiM.ShidojiY. (2016). Associations of buccal cell telomere length with daily intake of beta-carotene or alpha-tocopherol are dependent on carotenoid metabolism-related gene polymorphisms in healthy Japanese adults. J. Nutr. Health Aging20, 267–274. 10.1007/s12603-015-0577-x

  • CrossRef
  • Google Scholar

• 333

  YudaE.ShibataM.OgataY.UedaN.YambeT.YoshizawaM.et al (2020). Pulse rate variability: A new biomarker, not a surrogate for heart rate variability. J. Physiol. Anthropol.39, 21. 10.1186/s40101-020-00233-x

  • CrossRef
  • Google Scholar

• 334

  YudaE.UedaN.KisoharaM.HayanoJ. (2021). Redundancy among risk predictors derived from heart rate variability and dynamics: ALLSTAR big data analysis. Ann. Noninvasive Electrocardiol.26, e12790. 10.1111/anec.12790

  • CrossRef
  • Google Scholar

• 335

  YudaE.YamamotoK.YoshidaY.HayanoJ. (2020). Differences in pulse rate variability with measurement site. J. Physiol. Anthropol.39, 4. 10.1186/s40101-020-0214-1

  • CrossRef
  • Google Scholar

• 336

  ZaidA. N.Al RamahiR. (2019). Depigmentation and anti-aging treatment by natural molecules. Curr. Pharm. Des.25, 2292–2312. 10.2174/1381612825666190703153730

  • CrossRef
  • Google Scholar

• 337

  ZaslavskyO.CochraneB. B.ThompsonH. J.WoodsN. F.HertingJ. R.LaCroixA. (2013). Frailty: A review of the first decade of research. Biol. Res. Nurs.15, 422–432. 10.1177/1099800412462866

  • CrossRef
  • Google Scholar

• 338

  ZhaoJ.MooreA. N.CliftonG. L.DashP. K. (2005). Sulforaphane enhances aquaporin‐4 expression and decreases cerebral edema following traumatic brain injury. J. Neurosci. Res.82, 499–506. 10.1002/jnr.20649

  • CrossRef
  • Google Scholar

• 339

  ZhengY. L.ZhangF.SunB.DuJ.SunC.YuanJ.et al (2014). Telomerase enzymatic component hTERT shortens long telomeres in human cells. Cell. Cycle13, 1765–1776. 10.4161/cc.28705

  • CrossRef
  • Google Scholar

• 340

  ZhouJ.DingD.WangM.CongY. S. (2014). Telomerase reverse transcriptase in the regulation of gene expression. BMB Rep.47, 8–14. 10.5483/bmbrep.2014.47.1.284

  • CrossRef
  • Google Scholar

• 341

  ZhouY.HuG.WangM. C. (2021). Host and microbiota metabolic signals in aging and longevity. Nat. Chem. Biol.17, 1027–1036. 10.1038/s41589-021-00837-z

  • CrossRef
  • Google Scholar

• 342

  ZouY. X.RuanM. H.LuanJ.FengX.ChenS.ChuZ. Y. (2017). Anti-aging effect of riboflavin via endogenous antioxidant in fruit fly Drosophila melanogaster. J. Nutr. Health Aging21, 314–319. 10.1007/s12603-016-0752-8

  • CrossRef
  • Google Scholar